General Information of Drug (ID: DMNOKBV)

Drug Name
Phenytoin Drug Info
Synonyms
Aleviatin; Antisacer; Auranile; Causoin; Citrullamon; Citrulliamon; Comital; Comitoina; Convul; Danten; Dantinal; Dantoinal; Dantoine; Denyl; Difenilhidantoina; Difenin; Difetoin; Difhydan; Dihycon; Dihydantoin; Dilabid; Dilantin; Dilantine; Dillantin; Dintoin; Dintoina; Diphantoin; Diphedal; Diphedan; Diphenat; Diphenin; Diphenine; Diphentoin; Diphentyn; Diphenylan; Diphenylhydantoin; Diphenylhydantoine; Diphenylhydatanoin; Ditoinate; Ekko; Elepsindon; Enkelfel; Epamin; Epanutin; Epelin; Epifenyl; Epihydan; Epilantin; Epinat; Epised; Eptal; Eptoin; Fenitoin; Fenitoina; Fentoin; Fenylepsin; Fenytoine; Hidan; Hidantal; Hidantilo; Hidantina; Hidantomin; Hindatal; Hydantal; Hydantin; Hydantoinal; Hydantol; Idantoil; Idantoin; Iphenylhydantoin; Kessodanten; Labopal; Lehydan; Lepitoin; Lepsin; Minetoin; Neosidantoina; Novantoina; Novophenytoin; Oxylan; PHENYTEK; Phanantin; Phanatine; Phenatine; Phenatoine; Phenhydan; Phenhydanin; Phenitoin; Phentoin; Phentytoin; Phenytex; Phenytoine; Phenytoinum; Ritmenal; Saceril; Sanepil; Silantin; Sinergina; Sodanthon; Sodantoin; Sodanton; Solantin; Solantoin; Solantyl; Sylantoic;TOIN; Tacosal; Thilophenyl; Zentronal; Zentropil; Component of Mebroin; Dantoinal klinos; Difenilhidantoina [Spanish]; Dihydan toin; Dilantin acid; Diphenylhydantoine [French]; Ekko capsules; Elepsi ndon; Epdantoin Simple; Epdantoine simple; Epilan D; Extended Phenytoin Sodium; Fen toin; Fenantoin Mn Pharma; Fenidantoin s; Fenytoin Dak; Hidantina senosian; Hidantina vitoria; Ictalis simp le; Ictalis simple; Om hidantoina simple; Phenat ine; Phenytoin AWD; Sodium Diphenylhydantoinate; Taco sal; Toin unicelles; CL12003; D 4007; D4007_SIGMA; Didan TDC 250; Epasmir 5; IFLab1_000214; DILANTIN-30; DPH (VAN); Di-Hydan; Di-Lan; Di-Phetine; Dilantin (TN); Dilantin Infatabs (TN); Dilantin Kapseals (TN); Dilantin-125; Diphenylhydantoin (VAN); Epanutin (TN); Epasmir (5); Epilan-D; Eptoin (TN); Fenidantoin (s); Fenitoina [INN-Spanish]; Neos-Hidantoina; Om-Hydantoine; PHENYTOIN SODIUM, EXTENDED; Phenytek (TN); Phenytoin (PHN); Phenytoin-Gerot; Phenytoine [INN-French]; Phenytoinum [INN-Latin]; Di-Lan (VAN); Didan-tdc-250; Gerot-epilan-D; PHENYTOIN (5,5-DIPHENYLHYDANTOIN); Phenytoin (JP15/USP/INN); Phenytoin [USAN:INN:BAN:JAN]; Hydantoin, 5,5-diphenyl-(8CI); 2,4-Imidazolidinedione, 5,5-diphenyl-(9CI); 2-hydroxy-5,5-diphenyl-3,5-dihydro-4H-imidazol-4-one; 5,5-DIPHENYLHYDANTOIN; 5,5-Diphenyl-2,4-imidazolidinedione; 5,5-Diphenyl-imidazolidine-2,4-dione; 5,5-Diphenylhydantoin (IUPAC); 5,5-Diphenylhydantoin (phenytoin); 5,5-Diphenylimidazolidin-2,4-dione; 5,5-Dwufenylohydantoina; 5,5-Dwufenylohydantoina [Polish]; 5,5-diphenylimidazolidine-2,4-dione
Indication
Disease Entry ICD 11 Status REF
Epilepsy 8A60-8A68 Approved [1]
Epilepsy with generalized tonic-clonic seizures Approved [2]
Focal epilepsy Approved [2]
Primary motor cortex epilepsy Approved [2]
Therapeutic Class
Anticonvulsants
Cross-matching ID
PubChem CID
1775
ChEBI ID
CHEBI:8107
CAS Number
CAS 57-41-0
TTD Drug ID
DMNOKBV
VARIDT Drug ID
DR00431
INTEDE Drug ID
DR1282
ACDINA Drug ID
D00529

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
DTP
DME
DOT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
Patented Agent(s)
Preclinical Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [19]
Zonisamide DM0DTF7 Alcohol dependence 6C40.2 Approved [20]
Eslicarbazepine DMZREFQ Seizure disorder 8A6Z Approved [21]
LIDOFLAZINE DMV23GL Angina pectoris BA40 Approved [22]
LOMERIZINE DME0TC8 Migraine 8A80 Approved [23]
Levobupivacaine DM783CH Anaesthesia 9A78.6 Approved [24]
Tetrodotoxin DMWMPRG Bacterial infection 1A00-1C4Z Approved [25]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [26]
Rufinamide DMWE60C Epilepsy 8A60-8A68 Approved [27]
Butacaine DM584TM Pain MG30-MG3Z Approved [28]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [29]
Methotrexate DM2TEOL Anterior urethra cancer Approved [30]
Folic Acid DMEMBJC Colorectal carcinoma Approved [31]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [32]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [33]
Verapamil DMA7PEW Angina pectoris BA40 Approved [34]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [35]
Glutathione DMAHMT9 Human immunodeficiency virus infection 1C62 Approved [36]
Daunorubicin DMQUSBT Acute monocytic leukemia Approved [37]
Docetaxel DMDI269 Advanced cancer 2A00-2F9Z Approved [34]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [38]
Methotrexate DM2TEOL Anterior urethra cancer Approved [39]
Folic Acid DMEMBJC Colorectal carcinoma Approved [40]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [41]
Dinoprostone DMTYOPD Medical abortion JA00.1Z Approved [42]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [43]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [44]
Sulfasalazine DMICA9H Irritable bowel syndrome DD91.0 Approved [45]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [46]
Oxaliplatin DMQNWRD Adenocarcinoma 2D40 Approved [47]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Transported By P-glycoprotein 1 (ABCB1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Amoxicillin DMUYNEI Acute otitis media AB00 Approved [34]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [48]
Methotrexate DM2TEOL Anterior urethra cancer Approved [49]
Folic Acid DMEMBJC Colorectal carcinoma Approved [50]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [49]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [49]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [51]
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [49]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [52]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [53]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Metabolized By Cytochrome P450 3A4 (CYP3A4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [54]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [55]
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [56]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [57]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [58]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [59]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [60]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [61]
Prasterone DM67VKL Chronic obstructive pulmonary disease CA22 Approved [55]
Verapamil DMA7PEW Angina pectoris BA40 Approved [62]
Eplerenone DMF0NQR Heart failure BD10-BD13 Approved [119]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [120]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [121]
Voriconazole DMAOL2S Aspergillosis 1F20 Approved [122]
Proguanil DMBL79I Malaria 1F40-1F45 Approved [123]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [123]
Loratadine DMF3AN7 Allergy 4A80-4A85 Approved [124]
Nelfinavir mesylate DMFX6G8 N. A. N. A. Approved [125]
Capsaicin DMGMF6V Back pain ME84.Z Approved [126]
Axitinib DMGVH6N Renal cell carcinoma 2C90 Approved [127]
⏷ Show the Full List of 20 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [63]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [64]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [65]
Clofibrate DMPC1J7 Dysbetalipoproteinemia 5C80.2 Approved [66]
Trabectedin DMG3Y89 Leiomyosarcoma 2B58 Approved [67]
Busulfan DMXYJ9C Chronic myelogenous leukaemia 2A20.0 Approved [68]
Artemisinin DMOY7W3 Malaria 1F40-1F45 Approved [69]
Ethacrynic acid DM60QMR Edema MG29 Approved [70]
Tacrine DM51FY6 Alzheimer disease 8A20 Approved [71]
Melphalan DMOLNHF Hematologic disease 3C0Z Approved [72]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Metabolized By Cytochrome P450 3A5 (CYP3A5)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [73]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [74]
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [75]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [76]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [77]
Sulfasalazine DMICA9H Irritable bowel syndrome DD91.0 Approved [78]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [79]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [80]
Verapamil DMA7PEW Angina pectoris BA40 Approved [81]
Sorafenib DMS8IFC Adenocarcinoma 2D40 Approved [76]
Eplerenone DMF0NQR Heart failure BD10-BD13 Approved [119]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [120]
Nelfinavir mesylate DMFX6G8 N. A. N. A. Approved [125]
Ritonavir DMU764S Human immunodeficiency virus infection 1C62 Approved [125]
Ifosfamide DMCT3I8 Adult central nervous system germ cell tumor Approved [137]
Omeprazole DM471KJ Cystic fibrosis CA25 Approved [138]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [139]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [141]
Hydrocortisone DMGEMB7 Acne vulgaris ED80 Approved [142]
⏷ Show the Full List of 20 Drug(s)
Drug(s) Metabolized By Cytochrome P450 3A7 (CYP3A7)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Progesterone DMUY35B Amenorrhea GA20.0 Approved [82]
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [76]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [76]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [76]
Prasterone DM67VKL Chronic obstructive pulmonary disease CA22 Approved [10]
Verapamil DMA7PEW Angina pectoris BA40 Approved [83]
Sorafenib DMS8IFC Adenocarcinoma 2D40 Approved [76]
Quinine DMSWYF5 Malaria 1F40-1F45 Approved [76]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [76]
Metronidazole DMTIVEN Abscess Approved [84]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [153]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [138]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [154]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [155]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [152]
Prasterone DM67VKL Chronic obstructive pulmonary disease CA22 Approved [156]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [157]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [158]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [159]
⏷ Show the Full List of 20 Drug(s)
Drug(s) Metabolized By Cytochrome P450 2C18 (CYP2C18)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Verapamil DMA7PEW Angina pectoris BA40 Approved [10]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [85]
Propofol DMB4OLE Anaesthesia 9A78.6 Approved [86]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [87]
Diazepam DM08E9O Alcohol withdrawal Approved [88]
Methadone DMTW6IU Advanced cancer 2A00-2F9Z Approved [89]
Dapsone DM4LT8A Acne vulgaris ED80 Approved [90]
Lidocaine DML4ZOT Anaesthesia 9A78.6 Approved [10]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [91]
Ifosfamide DMCT3I8 Adult central nervous system germ cell tumor Approved [92]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Metabolized By Cytochrome P450 2C8 (CYP2C8)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [93]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [94]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [94]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [10]
Verapamil DMA7PEW Angina pectoris BA40 Approved [95]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [96]
Sorafenib DMS8IFC Adenocarcinoma 2D40 Approved [97]
Quinine DMSWYF5 Malaria 1F40-1F45 Approved [94]
Mycophenolate mofetil DMPQAGE Hepatosplenic T-cell lymphoma Approved [98]
Propofol DMB4OLE Anaesthesia 9A78.6 Approved [86]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Metabolized By Cytochrome P450 2C9 (CYP2C9)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Progesterone DMUY35B Amenorrhea GA20.0 Approved [99]
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [100]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [101]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [10]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [102]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [10]
Verapamil DMA7PEW Angina pectoris BA40 Approved [103]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [104]
Estrone DM5T6US Acne vulgaris ED80 Approved [105]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [106]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Metabolized By Cytochrome P450 2B6 (CYP2B6)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [107]
Verapamil DMA7PEW Angina pectoris BA40 Approved [10]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [108]
Estrone DM5T6US Acne vulgaris ED80 Approved [101]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [109]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [110]
Propofol DMB4OLE Anaesthesia 9A78.6 Approved [111]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [112]
Amitriptyline DMK7F9S Depression 6A70-6A7Z Approved [113]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [10]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [143]
Ritonavir DMU764S Human immunodeficiency virus infection 1C62 Approved [144]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [145]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [146]
Clopidogrel DMOL54H Acute coronary syndrome BA41 Approved [147]
Artemisinin DMOY7W3 Malaria 1F40-1F45 Approved [148]
Malathion DMXZ84M Pediculus capitis infestation 1G00.0 Approved [149]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [150]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [151]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [152]
⏷ Show the Full List of 20 Drug(s)
Drug(s) Metabolized By Mephenytoin 4-hydroxylase (CYP2C19)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Amoxicillin DMUYNEI Acute otitis media AB00 Approved [114]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [99]
Tamoxifen DMLB0EZ Breast cancer 2C60-2C65 Approved [115]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [116]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [10]
Verapamil DMA7PEW Angina pectoris BA40 Approved [117]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [85]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [106]
Quinine DMSWYF5 Malaria 1F40-1F45 Approved [118]
Propofol DMB4OLE Anaesthesia 9A78.6 Approved [86]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Artemisinin DMOY7W3 Malaria 1F40-1F45 Approved [69]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [128]
Thiotepa DMIZKOP Breast cancer 2C60-2C65 Approved [129]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [130]
Ethacrynic acid DM60QMR Edema MG29 Approved [131]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [132]
Busulfan DMXYJ9C Chronic myelogenous leukaemia 2A20.0 Approved [133]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [134]
Methotrexate DM2TEOL Anterior urethra cancer Approved [135]
Quercetin DM3NC4M Obesity 5B81 Approved [136]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cytochrome P450 2C19 (CYP2C19)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [120]
Thioridazine DM35M8J Schizophrenia 6A20 Approved [160]
Voriconazole DMAOL2S Aspergillosis 1F20 Approved [122]
Chloramphenicol DMFXEWT Bacterial infection 1A00-1C4Z Approved [143]
Capsaicin DMGMF6V Back pain ME84.Z Approved [161]
Pentamidine DMHZJCG African trypanosomiasis 1F51 Approved [123]
Stiripentol DMMSDOY Dravet syndrome 8A61.11 Approved [162]
Quinine DMSWYF5 Malaria 1F40-1F45 Approved [123]
Desipramine DMT2FDC Attention deficit hyperactivity disorder 6A05.Z Approved [160]
Amitriptyline DMK7F9S Depression 6A70-6A7Z Approved [14]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Flupentixol DM0DJ9O Schizophrenia 6A20 Approved [163]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [164]
Crizotinib DM4F29C Non-small-cell lung cancer 2C25.Y Approved [165]
Lamotrigine DM8SXYG Bipolar disorder 6A60 Approved [166]
Cepharanthine DM9Y5JB N. A. N. A. Approved [167]
Itraconazole DMCR1MV Aspergillosis 1F20 Approved [168]
Clozapine DMFC71L Schizophrenia 6A20 Approved [169]
Midostaurin DMI6E0R Acute myeloid leukaemia 2A60 Approved [170]
Trifluoperazine DMKBYWI Anxiety Approved [171]
Olanzapine DMPFN6Y Bipolar depression Approved [169]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Lopinavir DMITQS0 Human immunodeficiency virus infection 1C62 Approved [172]
Sulfinpyrazone DMEV954 Gout FA25 Approved [173]
Probenecid DMMFWOJ Acute gonococcal cervicitis Approved [174]
Docetaxel DMDI269 Advanced cancer 2A00-2F9Z Approved [175]
Methotrexate DM2TEOL Anterior urethra cancer Approved [176]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [177]
Cholic Acid DM7OKQV Cholelithiasis DC11 Approved [178]
Epirubicin DMPDW6T Solid tumour/cancer 2A00-2F9Z Approved [179]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [180]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [181]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [182]
Allopurinol DMLPAOB Gout FA25 Approved [183]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [184]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [141]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [185]
Amoxicillin DMUYNEI Acute otitis media AB00 Approved [186]
Abacavir DMMN36E Human immunodeficiency virus infection 1C62 Approved [187]
Flucloxacillin DMNUWST Bacterial infection 1A00-1C4Z Approved [188]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [189]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [190]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [191]
Allopurinol DMLPAOB Gout FA25 Approved [192]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [184]
Ticlopidine DMO946V Acute coronary syndrome BA41 Approved [193]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [194]
Selenium DM25CGV N. A. N. A. Approved [195]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [196]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [197]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [198]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [199]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [200]
Allopurinol DMLPAOB Gout FA25 Approved [201]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [192]
Clavulanate DM2FGRT Bacteremia 1A73 Approved [189]
Ticlopidine DMO946V Acute coronary syndrome BA41 Approved [193]
Amoxicillin DMUYNEI Acute otitis media AB00 Approved [189]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [202]
Erythromycin DM4K7GQ Acne vulgaris ED80 Approved [186]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [186]
Bupropion DM5PCS7 Depression 6A70-6A7Z Approved [186]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cytochrome P450 1A1 (CYP1A1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Amodiaquine DME4RA8 Malaria 1F40-1F45 Approved [203]
Riluzole DMECBWN Amyotrophic lateral sclerosis 8B60.0 Approved [204]
Flutamide DMK0O7U Prostate cancer 2C82.0 Approved [205]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [206]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [207]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [208]
Ethacrynic acid DM60QMR Edema MG29 Approved [209]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [210]
Ethinyl Estradiol DMODJ40 Acne vulgaris ED80 Approved [211]
Clofibrate DMPC1J7 Dysbetalipoproteinemia 5C80.2 Approved [212]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [213]
Methotrexate DM2TEOL Anterior urethra cancer Approved [214]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [215]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [216]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [217]
Paclitaxel DMLB81S Breast carcinoma Approved [218]
Floxuridine DM04LR2 Colorectal cancer 2B91.Z Approved [219]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [220]
Mechlorethamine DM0CVXA Chronic myelogenous leukaemia 2A20.0 Approved [221]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [222]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Verapamil DMA7PEW Angina pectoris BA40 Approved [223]
Vidarabine DM0N85H Hepatosplenic T-cell lymphoma Approved [223]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [224]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [225]
Secobarbital DM14RF5 Epilepsy 8A60-8A68 Approved [226]
Etidronic acid DM1XHYJ Bone Paget disease Approved [223]
Tiaprofenic acid DM23D7J Osteoarthritis FA00-FA05 Approved [223]
Bromperidol DM24XYQ Schizophrenia 6A20 Approved [223]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [227]
Deoxycholic acid DM3GYAL Subcutaneous fat disorder EF02 Approved [228]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Aromatase (CYP19A1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Letrozole DMH07Y3 Estrogen-receptor positive breast cancer Approved [229]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [230]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [231]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [232]
Citalopram DM2G9AE Acute coronary syndrome BA41 Approved [231]
Methotrexate DM2TEOL Anterior urethra cancer Approved [214]
FADROZOLE DM3C5GZ Breast cancer 2C60-2C65 Approved [233]
Bifonazole DM3KN7V Fungal infection 1F29-1F2F Approved [234]
Quercetin DM3NC4M Obesity 5B81 Approved [235]
Fluoxetine DM3PD2C Bipolar depression Approved [231]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cytochrome P450 2E1 (CYP2E1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fomepizole DM6VOWQ Athylene glycol or methanol poisoning NE61 Approved [236]
Ademetionine DMYQDBO Hepatic fibrosis DB93.0 Approved [237]
Theophylline DMRJFN9 Bronchitis CA20 Approved [14]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [238]
Ethanol DMDRQZU Chronic pain MG30 Approved [239]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [240]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [241]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [141]
Didanosine DMI2QPE Human immunodeficiency virus infection 1C62 Approved [14]
Thioridazine DM35M8J Schizophrenia 6A20 Approved [160]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Primidone DM0WX6I Epilepsy 8A60-8A68 Approved [242]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [243]
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [244]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [245]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [246]
Quercetin DM3NC4M Obesity 5B81 Approved [247]
Panobinostat DM58WKG Chronic graft versus host disease Approved [248]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [249]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [250]
Gabapentin DM6T924 Complex partial seizure 8A68.0 Approved [242]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Neurocan core protein (NCAN)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [251]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [252]
Arsenic DMTL2Y1 N. A. N. A. Approved [253]
PDX-101 DM6OC53 Plasma cell myeloma 2A83.1 Phase 2 [248]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [254]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [255]
Deguelin DMXT7WG Esophageal squamous cell carcinoma 2E60.1 Investigative [256]
⏷ Show the Full List of 7 Drug(s)
Drug(s) Affected By Plexin-B2 (PLXNB2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [195]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [257]
Quercetin DM3NC4M Obesity 5B81 Approved [136]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [141]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [258]
Arsenic DMTL2Y1 N. A. N. A. Approved [259]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [181]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [260]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [261]
Adenine DMZLHKJ Malnutrition 5B50-5B71 Approved [257]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Calpain-5 (CAPN5)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Leflunomide DMR8ONJ Arthritis FA20 Approved [262]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [263]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [141]
Ethanol DMDRQZU Chronic pain MG30 Approved [264]
Mifepristone DMGZQEF Cushing disease 5A70 Approved [265]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [266]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [267]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [268]
Arsenic DMTL2Y1 N. A. N. A. Approved [259]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [261]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Panobinostat DM58WKG Chronic graft versus host disease Approved [248]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [263]
Testosterone enanthate DMB6871 N. A. N. A. Approved [269]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [141]
Mifepristone DMGZQEF Cushing disease 5A70 Approved [265]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [240]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [270]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [271]
Cytarabine DMZD5QR Acute lymphoblastic leukaemia 2A85 Approved [272]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [273]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Lathosterol oxidase (SC5D)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [134]
Fluoxetine DM3PD2C Bipolar depression Approved [274]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [158]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [202]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [275]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [276]
Testosterone DM7HUNW Hot flushes GA30 Approved [277]
Haloperidol DM96SE0 Delirium Approved [276]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [278]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [279]
Polyethylene glycol DM4I1JP Constipation DD91.1 Approved [279]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [279]
Panobinostat DM58WKG Chronic graft versus host disease Approved [248]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [279]
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [279]
Ramelteon DM7IW9J Insomnia 7A00-7A0Z Approved [279]
Disulfiram DMCL2OK Alcohol dependence 6C40.2 Approved [280]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [141]
Dabigatran DMDI6R4 Stroke 8B20 Approved [279]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Eomesodermin homolog (EOMES)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [281]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [282]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [278]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [283]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [267]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [284]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [285]
Arsenic DMTL2Y1 N. A. N. A. Approved [286]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [184]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [273]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Pentoxifylline DMU3DNC Alcoholic hepatitis DB94.1 Approved [14]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [287]
Verapamil DMA7PEW Angina pectoris BA40 Approved [288]
Selenium DM25CGV N. A. N. A. Approved [289]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [288]
Quercetin DM3NC4M Obesity 5B81 Approved [290]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [158]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [196]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [291]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [292]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [293]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [294]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [295]
Gefitinib DM15F0X Colon adenocarcinoma Approved [296]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [297]
Selenium DM25CGV N. A. N. A. Approved [298]
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [299]
Trametinib DM2JGQ3 Melanoma 2C30 Approved [300]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [301]
Methotrexate DM2TEOL Anterior urethra cancer Approved [214]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [302]
Ramipril DM2R68E Acute heart failure BD10-BD13 Approved [303]
Methotrexate DM2TEOL Anterior urethra cancer Approved [214]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [304]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [305]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [306]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [307]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [141]
Ethanol DMDRQZU Chronic pain MG30 Approved [305]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [308]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Parathyroid hormone (PTH)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [309]
Cinacalcet DMCX0K3 Hyperparathyroidism 5A51 Approved [310]
Cholecalciferol DMGU74E Adult acute monocytic leukemia Approved [311]
Arsenic DMTL2Y1 N. A. N. A. Approved [259]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [312]
Phosphate DMUXQG7 Constipation DD91.1 Approved [313]
Paricalcitol DMYBV3G Hyperparathyroidism 5A51 Approved [314]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [14]
Cimetidine DMH61ZB Acid-reflux disorder DA22 Approved [14]
Seocalcitol DMKL9QO Rickets 5B57 Phase 3 [315]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Tumor necrosis factor (TNF)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Indomethacin DMSC4A7 Bursitis Approved [316]
Amphotericin B DMTAJQE Acne vulgaris ED80 Approved [317]
Fructose DM43AN2 Vomiting MD90 Approved [14]
Ketoprofen DMRKXPT Bursitis Approved [14]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [318]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [319]
Baclofen DM0QV1J Multiple sclerosis 8A40 Approved [320]
Gefitinib DM15F0X Colon adenocarcinoma Approved [321]
Ganciclovir DM1MBYQ Cytomegalovirus infection 1D82 Approved [322]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [323]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Penicillamine DM40EF6 Cystinuria 5C60.2 Approved [14]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [324]
Diazepam DM08E9O Alcohol withdrawal Approved [325]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [326]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [327]
Methotrexate DM2TEOL Anterior urethra cancer Approved [328]
Ceruletide DM2WE5K Caerulein stimulated gastric and pancreatic secretion 5A4Y Approved [329]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [330]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [331]
Quercetin DM3NC4M Obesity 5B81 Approved [332]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Fibronectin (FN1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [333]
Methotrexate DM2TEOL Anterior urethra cancer Approved [214]
Quercetin DM3NC4M Obesity 5B81 Approved [334]
Aripiprazole DM3NUMH Bipolar I disorder Approved [335]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [336]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [337]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [275]
Ethacrynic acid DM60QMR Edema MG29 Approved [338]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [339]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [340]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Alpha-fetoprotein (AFP)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [341]
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [342]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [343]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [251]
Isoniazid DM5JVS3 Latent tuberculosis infection Approved [341]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [344]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [345]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [307]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [278]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [346]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [347]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [348]
Etretinate DM2CZFA Keratosis ED56 Approved [349]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [350]
Methotrexate DM2TEOL Anterior urethra cancer Approved [351]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [352]
Quercetin DM3NC4M Obesity 5B81 Approved [353]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [354]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [355]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [297]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [134]
Ramipril DM2R68E Acute heart failure BD10-BD13 Approved [303]
Methotrexate DM2TEOL Anterior urethra cancer Approved [351]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [356]
Panobinostat DM58WKG Chronic graft versus host disease Approved [248]
Estrone DM5T6US Acne vulgaris ED80 Approved [357]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [358]
Leflunomide DMR8ONJ Arthritis FA20 Approved [262]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [141]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Integrin beta-1 (ITGB1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [359]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [326]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [360]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [194]
Methotrexate DM2TEOL Anterior urethra cancer Approved [361]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [362]
Fructose DM43AN2 Vomiting MD90 Approved [363]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [364]
Polyethylene glycol DM4I1JP Constipation DD91.1 Approved [365]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [366]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Insulin receptor (INSR)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [367]
Methotrexate DM2TEOL Anterior urethra cancer Approved [214]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [356]
Testosterone DM7HUNW Hot flushes GA30 Approved [368]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [255]
Sulfasalazine DMICA9H Irritable bowel syndrome DD91.0 Approved [369]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [370]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [371]
Methamphetamine DMPM4SK Anxiety Approved [370]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Creatine kinase M-type (CKM)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [372]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [358]
Mitoxantrone DMM39BF Acute myelogenous leukaemia 2A41 Approved [373]
Salbutamol DMN9CWF Acute asthma CA23 Approved [374]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [375]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [376]
Daunorubicin DMQUSBT Acute monocytic leukemia Approved [373]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [377]
Carbimazole DMULAI4 Hyperthyroidism 5A02 Approved [378]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [373]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Procathepsin L (CTSL)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [202]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [379]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [380]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [278]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [258]
Amodiaquine DME4RA8 Malaria 1F40-1F45 Approved [381]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [382]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [383]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [376]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [384]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cathepsin B (CTSB)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [385]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [326]
Selenium DM25CGV N. A. N. A. Approved [195]
Quercetin DM3NC4M Obesity 5B81 Approved [136]
Omeprazole DM471KJ Cystic fibrosis CA25 Approved [386]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [251]
Pyrimethamine DM5X7VY Malaria 1F40-1F45 Approved [387]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [388]
Propylthiouracil DM6D7N8 Hyperthyroidism 5A02 Approved [389]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [390]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [364]
Panobinostat DM58WKG Chronic graft versus host disease Approved [248]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [358]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [391]
Aldosterone DM9S2JW Hypertension BA00-BA04 Approved [392]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [393]
Testosterone enanthate DMB6871 N. A. N. A. Approved [269]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [141]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [258]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [394]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [297]
Arsenic DMTL2Y1 N. A. N. A. Approved [259]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [261]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [348]
Selenium DM25CGV N. A. N. A. Approved [289]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [395]
Quercetin DM3NC4M Obesity 5B81 Approved [396]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [397]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [398]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [275]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [291]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [292]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [399]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Stromelysin-1 (MMP3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [14]
Fluvastatin DM4MDJY Arteriosclerosis BD40 Approved [14]
Pravastatin DM6A0X7 Adult acute monocytic leukemia Approved [14]
Atorvastatin DMF28YC Acute coronary syndrome BA41 Approved [14]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [359]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [400]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [350]
Methotrexate DM2TEOL Anterior urethra cancer Approved [401]
Quercetin DM3NC4M Obesity 5B81 Approved [402]
Rofecoxib DM3P5DA Osteoarthritis FA00-FA05 Approved [354]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [403]
Quercetin DM3NC4M Obesity 5B81 Approved [404]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [364]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [405]
Propofol DMB4OLE Anaesthesia 9A78.6 Approved [406]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [258]
Dopamine DMPGUCF Acromegaly 5A60.0 Approved [407]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [268]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [408]
Cocaine DMSOX7I Anaesthesia 9A78.6 Approved [409]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Annexin A4 (ANXA4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [134]
Quercetin DM3NC4M Obesity 5B81 Approved [410]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [251]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [307]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [411]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [258]
Enzalutamide DMGL19D Prostate cancer 2C82.0 Approved [412]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [413]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [267]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [394]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [251]
Polyethylene glycol DM4I1JP Constipation DD91.1 Approved [279]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [279]
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [279]
Ramelteon DM7IW9J Insomnia 7A00-7A0Z Approved [279]
Testosterone enanthate DMB6871 N. A. N. A. Approved [269]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [278]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [267]
Abacavir DMMN36E Human immunodeficiency virus infection 1C62 Approved [279]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [414]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Calmodulin-1 (CALM2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [134]
Selenium DM25CGV N. A. N. A. Approved [195]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [415]
Methotrexate DM2TEOL Anterior urethra cancer Approved [351]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [415]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [416]
Leflunomide DMR8ONJ Arthritis FA20 Approved [262]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [141]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [258]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Diazepam DM08E9O Alcohol withdrawal Approved [325]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [232]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [134]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [158]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [356]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [417]
Testosterone DM7HUNW Hot flushes GA30 Approved [418]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [419]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [418]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [263]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [420]
Melphalan DMOLNHF Hematologic disease 3C0Z Approved [421]
Arsenic DMTL2Y1 N. A. N. A. Approved [422]
Ardeparin DMYRX8B Deep vein thrombosis BD71 Approved [423]
Warfarin DMJYCVW Atrial fibrillation BC81.3 Approved [424]
Paclitaxel DMLB81S Breast carcinoma Approved [425]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [425]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [426]
Suramin DMTOUY9 African trypanosomiasis 1F51 Phase 1 [427]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [254]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [251]
Panobinostat DM58WKG Chronic graft versus host disease Approved [428]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [429]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [391]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [430]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [278]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [420]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [267]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [431]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [432]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [153]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [153]
Panobinostat DM58WKG Chronic graft versus host disease Approved [248]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Testosterone enanthate DMB6871 N. A. N. A. Approved [269]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [141]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [258]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [433]
Paclitaxel DMLB81S Breast carcinoma Approved [434]
Alitretinoin DMME8LH Kaposi sarcoma 2B57 Approved [153]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [435]
Selenium DM25CGV N. A. N. A. Approved [195]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [275]
Testosterone enanthate DMB6871 N. A. N. A. Approved [269]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [141]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [433]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [413]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [267]
Paclitaxel DMLB81S Breast carcinoma Approved [434]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [394]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [275]
Panobinostat DM58WKG Chronic graft versus host disease Approved [248]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [358]
Liothyronine DM6IR3P Congenital hypothyroidism Approved [436]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [430]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [141]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [267]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [394]
Azacitidine DMTA5OE Acute myelogenous leukaemia 2A41 Approved [437]
Arsenic DMTL2Y1 N. A. N. A. Approved [259]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [351]
Quercetin DM3NC4M Obesity 5B81 Approved [334]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [141]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [438]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [377]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [261]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [439]
Seocalcitol DMKL9QO Rickets 5B57 Phase 3 [440]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [441]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [442]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [359]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [134]
Methotrexate DM2TEOL Anterior urethra cancer Approved [351]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [202]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [443]
Leflunomide DMR8ONJ Arthritis FA20 Approved [262]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [430]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [141]
Clozapine DMFC71L Schizophrenia 6A20 Approved [444]
Pentamidine DMHZJCG African trypanosomiasis 1F51 Approved [445]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
DTI-015 DMXZRW0 Brain cancer 2A00 Approved [446]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [379]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [447]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Disulfiram DMCL2OK Alcohol dependence 6C40.2 Approved [448]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [258]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [449]
Dacarbazine DMNPZL4 Adenocarcinoma 2D40 Approved [450]
Topotecan DMP6G8T Central nervous system neoplasm Approved [451]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [451]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Integrin alpha-2 (ITGA2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [400]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [415]
Quercetin DM3NC4M Obesity 5B81 Approved [136]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [452]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [251]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [453]
Testosterone DM7HUNW Hot flushes GA30 Approved [418]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [418]
Leflunomide DMR8ONJ Arthritis FA20 Approved [262]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [454]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [134]
Methotrexate DM2TEOL Anterior urethra cancer Approved [135]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [202]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [405]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [279]
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [279]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [141]
Dabigatran DMDI6R4 Stroke 8B20 Approved [279]
Abacavir DMMN36E Human immunodeficiency virus infection 1C62 Approved [279]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [455]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [456]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [294]
Gefitinib DM15F0X Colon adenocarcinoma Approved [457]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [194]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [458]
Methotrexate DM2TEOL Anterior urethra cancer Approved [459]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [460]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [461]
Quercetin DM3NC4M Obesity 5B81 Approved [462]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Midkine (MDK)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [195]
Quercetin DM3NC4M Obesity 5B81 Approved [136]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [452]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [463]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [307]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [141]
Enzalutamide DMGL19D Prostate cancer 2C82.0 Approved [412]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [267]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [394]
Piroxicam DMTK234 Osteoarthritis FA00-FA05 Approved [464]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Diazepam DM08E9O Alcohol withdrawal Approved [325]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [134]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [465]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [297]
Lenalidomide DM6Q7U4 Adult T-cell leukemia/lymphoma Approved [466]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [466]
Testosterone DM7HUNW Hot flushes GA30 Approved [418]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [418]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [263]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [411]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [467]
Polyethylene glycol DM4I1JP Constipation DD91.1 Approved [279]
Panobinostat DM58WKG Chronic graft versus host disease Approved [248]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [279]
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [279]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [411]
Dabigatran DMDI6R4 Stroke 8B20 Approved [279]
Folic Acid DMEMBJC Colorectal carcinoma Approved [468]
Abacavir DMMN36E Human immunodeficiency virus infection 1C62 Approved [279]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [284]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Indomethacin DMSC4A7 Bursitis Approved [469]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [470]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [471]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [472]
Gefitinib DM15F0X Colon adenocarcinoma Approved [473]
Talazoparib DM1KS78 Breast cancer 2C60-2C65 Approved [474]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [475]
Selenium DM25CGV N. A. N. A. Approved [195]
Ribavirin DMEYLH9 Hepatitis C virus infection 1E51.1 Approved [299]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [476]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fructose DM43AN2 Vomiting MD90 Approved [14]
Aprepitant DM053KT Depression 6A70-6A7Z Approved [477]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [359]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [478]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [479]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [480]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [481]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [482]
Deoxycholic acid DM3GYAL Subcutaneous fat disorder EF02 Approved [483]
Quercetin DM3NC4M Obesity 5B81 Approved [136]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [251]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [279]
Panobinostat DM58WKG Chronic graft versus host disease Approved [248]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [279]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [484]
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [279]
Ramelteon DM7IW9J Insomnia 7A00-7A0Z Approved [279]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [485]
Dabigatran DMDI6R4 Stroke 8B20 Approved [279]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein S100-A4 (S100A4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [486]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [251]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [275]
Panobinostat DM58WKG Chronic graft versus host disease Approved [248]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [487]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [488]
Adenosine triphosphate DM79F6G Malnutrition 5B50-5B71 Approved [489]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [391]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [307]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [141]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [490]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [491]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [492]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [319]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [493]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [494]
Secobarbital DM14RF5 Epilepsy 8A60-8A68 Approved [495]
Gefitinib DM15F0X Colon adenocarcinoma Approved [496]
Fexofenadine DM17ONX Allergic rhinitis CA08.0 Approved [497]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [498]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ethanol DMDRQZU Chronic pain MG30 Approved [499]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [491]
Carvedilol DMHTEAO Chronic heart failure BD1Z Approved [500]
Paclitaxel DMLB81S Breast carcinoma Approved [501]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [502]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [490]
Urokinase DM0GOUD Myocardial infarction BA41-BA43 Approved [14]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [359]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [319]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [493]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [503]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [251]
Panobinostat DM58WKG Chronic graft versus host disease Approved [248]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [278]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [504]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [420]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [505]
Arsenic DMTL2Y1 N. A. N. A. Approved [259]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [506]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [248]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [326]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [326]
Testosterone DM7HUNW Hot flushes GA30 Approved [418]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [418]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [258]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [431]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [507]
DNCB DMDTVYC Immune System disease 4A01-4B41 Phase 2 [508]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [254]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [359]
Quercetin DM3NC4M Obesity 5B81 Approved [334]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [202]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [509]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [141]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [376]
Arsenic DMTL2Y1 N. A. N. A. Approved [259]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [181]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [261]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [254]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [510]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [511]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [360]
Gefitinib DM15F0X Colon adenocarcinoma Approved [512]
Talazoparib DM1KS78 Breast cancer 2C60-2C65 Approved [474]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [513]
Etretinate DM2CZFA Keratosis ED56 Approved [514]
Prednisone DM2HG4X Acute asthma CA23 Approved [515]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [516]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [257]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [435]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [134]
Selenium DM25CGV N. A. N. A. Approved [195]
Quercetin DM3NC4M Obesity 5B81 Approved [136]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [364]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [141]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [258]
Capsaicin DMGMF6V Back pain ME84.Z Approved [517]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [504]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [136]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [141]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [258]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [240]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [507]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [273]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [518]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [195]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [254]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [519]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [385]
Quercetin DM3NC4M Obesity 5B81 Approved [136]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [251]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [358]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [520]
Leflunomide DMR8ONJ Arthritis FA20 Approved [262]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [136]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [278]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [258]
Folic Acid DMEMBJC Colorectal carcinoma Approved [521]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [522]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [523]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [307]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [278]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [258]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [267]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [524]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [376]
Arsenic DMTL2Y1 N. A. N. A. Approved [259]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [377]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Homeobox protein MOX-1 (MEOX1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [326]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [279]
Polyethylene glycol DM4I1JP Constipation DD91.1 Approved [279]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [279]
Panobinostat DM58WKG Chronic graft versus host disease Approved [248]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [525]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [279]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [443]
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [279]
Ramelteon DM7IW9J Insomnia 7A00-7A0Z Approved [279]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [202]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Lindane DMB8CNL Infestations of lice and scabies 1G00.Z Approved [526]
Ursodeoxycholic acid DMCUT21 Cholelithiasis DC11 Approved [527]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [258]
Menthol DMG2KW7 Back pain ME84.Z Approved [528]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [529]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [267]
Bortezomib DMNO38U Leukemia Approved [530]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [531]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Integrin alpha-8 (ITGA8)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [251]
Panobinostat DM58WKG Chronic graft versus host disease Approved [248]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [278]
Arsenic DMTL2Y1 N. A. N. A. Approved [259]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [248]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [254]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [532]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [255]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [214]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [251]
Panobinostat DM58WKG Chronic graft versus host disease Approved [248]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [279]
Ramelteon DM7IW9J Insomnia 7A00-7A0Z Approved [279]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [141]
Dolutegravir DMCZGRE Human immunodeficiency virus infection 1C62 Approved [533]
Dabigatran DMDI6R4 Stroke 8B20 Approved [279]
Folic Acid DMEMBJC Colorectal carcinoma Approved [468]
Abacavir DMMN36E Human immunodeficiency virus infection 1C62 Approved [279]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Neurotrypsin (PRSS12)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [202]
Panobinostat DM58WKG Chronic graft versus host disease Approved [248]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [534]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [263]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [278]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [267]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [376]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [408]
Azacitidine DMTA5OE Acute myelogenous leukaemia 2A41 Approved [437]
Arsenic DMTL2Y1 N. A. N. A. Approved [535]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein S100-A10 (S100A10)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [202]
Panobinostat DM58WKG Chronic graft versus host disease Approved [248]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [536]
Adenosine triphosphate DM79F6G Malnutrition 5B50-5B71 Approved [489]
Testosterone DM7HUNW Hot flushes GA30 Approved [418]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [418]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [307]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [278]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [258]
Folic Acid DMEMBJC Colorectal carcinoma Approved [521]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [135]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [364]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [391]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [141]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [267]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [376]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [537]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [254]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [435]
Deguelin DMXT7WG Esophageal squamous cell carcinoma 2E60.1 Investigative [256]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [196]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [456]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [278]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [258]
Menthol DMG2KW7 Back pain ME84.Z Approved [528]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [267]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [376]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [538]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [285]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Transcription factor Sp3 (SP3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [539]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [539]
Plicamycin DM7C8YV Hypercalcaemia 5B91.0 Approved [540]
Leflunomide DMR8ONJ Arthritis FA20 Approved [262]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [541]
Promegestone DMK4S8I Gynecological disease GA6Z Approved [542]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [543]
Daunorubicin DMQUSBT Acute monocytic leukemia Approved [544]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [261]
Vitamin C DMXJ7O8 Adenocarcinoma 2D40 Approved [545]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [546]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [547]
Quercetin DM3NC4M Obesity 5B81 Approved [548]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [549]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [297]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [550]
Testosterone DM7HUNW Hot flushes GA30 Approved [418]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [419]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [418]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [136]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Fibromodulin (FMOD)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Diazepam DM08E9O Alcohol withdrawal Approved [325]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [134]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [525]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [248]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [261]
Methotrexate DM2TEOL Anterior urethra cancer Approved [425]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [425]
Urethane DM7NSI0 N. A. N. A. Phase 4 [551]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [428]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [254]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Metoclopramide DMFA5MY Nausea MD90 Approved [552]
Quinidine DMLPICK N. A. N. A. Approved [553]
Verapamil DMA7PEW Angina pectoris BA40 Approved [554]
Erythromycin DM4K7GQ Acne vulgaris ED80 Approved [555]
Clarithromycin DM4M1SG Acute maxillary sinusitis Approved [555]
Disopyramide DM5SYZP Long QT syndrome BC65.0 Approved [556]
Propranolol DM79NTF Angina pectoris BA40 Approved [557]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [558]
Dofetilide DMPN1TW Sinus rhythm disorder BC9Y Approved [559]
Flecainide DMSQDLE Tachyarrhythmias BC71 Approved [555]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [279]
Polyethylene glycol DM4I1JP Constipation DD91.1 Approved [279]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [279]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [279]
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [279]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [279]
Dabigatran DMDI6R4 Stroke 8B20 Approved [279]
Abacavir DMMN36E Human immunodeficiency virus infection 1C62 Approved [279]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [279]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [254]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [195]
Fluoxetine DM3PD2C Bipolar depression Approved [274]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [158]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [266]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [196]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [275]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [141]
Ethanol DMDRQZU Chronic pain MG30 Approved [560]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [438]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [214]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [561]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [443]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [263]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [248]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [561]
Prednisolone DMQ8FR2 Acute adrenal insufficiency Approved [561]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [285]
Piroxicam DMTK234 Osteoarthritis FA00-FA05 Approved [561]
Arsenic DMTL2Y1 N. A. N. A. Approved [253]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [227]
Quercetin DM3NC4M Obesity 5B81 Approved [562]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [563]
Artemether DM48QOT Malaria 1F40-1F45 Approved [564]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [565]
Nefazodone DM4ZS8M Major depressive disorder 6A70.3 Approved [566]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [567]
Estrone DM5T6US Acne vulgaris ED80 Approved [568]
Leflunomide DMR8ONJ Arthritis FA20 Approved [569]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [279]
Polyethylene glycol DM4I1JP Constipation DD91.1 Approved [279]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [279]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [279]
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [279]
Ramelteon DM7IW9J Insomnia 7A00-7A0Z Approved [279]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [284]
Dabigatran DMDI6R4 Stroke 8B20 Approved [279]
Ethanol DMDRQZU Chronic pain MG30 Approved [264]
Abacavir DMMN36E Human immunodeficiency virus infection 1C62 Approved [279]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Caspase-10 (CASP10)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [435]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [486]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [570]
Methotrexate DM2TEOL Anterior urethra cancer Approved [135]
Quercetin DM3NC4M Obesity 5B81 Approved [571]
obeticholic acid DM3Q1SM Primary biliary cholangitis DB96.1 Approved [158]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [208]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [202]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [572]
Testosterone DM7HUNW Hot flushes GA30 Approved [277]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [573]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [574]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [525]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [573]
Lamotrigine DM8SXYG Bipolar disorder 6A60 Approved [575]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [263]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [199]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [267]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [576]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [254]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Eyes absent homolog 1 (EYA1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [435]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [364]
Polyethylene glycol DM4I1JP Constipation DD91.1 Approved [279]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [279]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [279]
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [279]
Ramelteon DM7IW9J Insomnia 7A00-7A0Z Approved [279]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [279]
Dabigatran DMDI6R4 Stroke 8B20 Approved [279]
Abacavir DMMN36E Human immunodeficiency virus infection 1C62 Approved [279]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [511]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [279]
Polyethylene glycol DM4I1JP Constipation DD91.1 Approved [279]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [279]
Panobinostat DM58WKG Chronic graft versus host disease Approved [248]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [279]
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [279]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [279]
Dabigatran DMDI6R4 Stroke 8B20 Approved [279]
Abacavir DMMN36E Human immunodeficiency virus infection 1C62 Approved [279]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Captopril DM458UM Chronic heart failure BD1Z Approved [577]
Diazepam DM08E9O Alcohol withdrawal Approved [16]
Dantrolene DM1D8XY Hyperthermia MG26 Approved [16]
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [16]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [16]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [16]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [16]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [16]
Penicillamine DM40EF6 Cystinuria 5C60.2 Approved [16]
Omeprazole DM471KJ Cystic fibrosis CA25 Approved [16]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Neurogenin-2 (NEUROG2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [364]
Polyethylene glycol DM4I1JP Constipation DD91.1 Approved [279]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [279]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [279]
Nilotinib DM7HXWT Chronic myelogenous leukaemia 2A20.0 Approved [279]
Leflunomide DMR8ONJ Arthritis FA20 Approved [262]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [141]
Dabigatran DMDI6R4 Stroke 8B20 Approved [279]
Folic Acid DMEMBJC Colorectal carcinoma Approved [284]
Abacavir DMMN36E Human immunodeficiency virus infection 1C62 Approved [279]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [573]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [141]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [254]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [578]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [255]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [196]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [579]
Testosterone DM7HUNW Hot flushes GA30 Approved [418]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [418]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [141]
Menthol DMG2KW7 Back pain ME84.Z Approved [528]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [432]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [376]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [580]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [285]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [136]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [251]
Testosterone DM7HUNW Hot flushes GA30 Approved [277]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Testosterone enanthate DMB6871 N. A. N. A. Approved [269]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [283]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [258]
Bortezomib DMNO38U Leukemia Approved [438]
Piroxicam DMTK234 Osteoarthritis FA00-FA05 Approved [464]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [181]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [326]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [479]
Quercetin DM3NC4M Obesity 5B81 Approved [136]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [258]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [376]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [240]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [414]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [507]
Isoflavone DM7U58J N. A. N. A. Phase 4 [581]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [214]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [202]
Leflunomide DMR8ONJ Arthritis FA20 Approved [262]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [582]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [376]
Piroxicam DMTK234 Osteoarthritis FA00-FA05 Approved [464]
Arsenic DMTL2Y1 N. A. N. A. Approved [259]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [583]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [308]
Urethane DM7NSI0 N. A. N. A. Phase 4 [551]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Epoxide hydrolase 1 (EPHX1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [152]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [202]
Nefazodone DM4ZS8M Major depressive disorder 6A70.3 Approved [566]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [238]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [584]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [443]
Plicamycin DM7C8YV Hypercalcaemia 5B91.0 Approved [585]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [141]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [258]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [364]
Panobinostat DM58WKG Chronic graft versus host disease Approved [248]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [141]
Ethinyl Estradiol DMODJ40 Acne vulgaris ED80 Approved [586]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [376]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [587]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [184]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [439]
Chlorothiazide DMLHESP Chronic heart failure BD1Z Approved [588]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [589]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Paclitaxel DMLB81S Breast carcinoma Approved [14]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [181]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [324]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [327]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [590]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [251]
Procaine DM4LSNE Anaesthesia 9A78.6 Approved [591]
Glucosamine DM4ZLFD Osteoarthritis FA00-FA05 Approved [592]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [593]
Aldosterone DM9S2JW Hypertension BA00-BA04 Approved [594]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Aspirin DM672AH Acute coronary syndrome BA41 Approved [415]
Testosterone DM7HUNW Hot flushes GA30 Approved [418]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [418]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [377]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [261]
Urethane DM7NSI0 N. A. N. A. Phase 4 [551]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [595]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [136]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [364]
Testosterone enanthate DMB6871 N. A. N. A. Approved [269]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [411]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [596]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [285]
Arsenic DMTL2Y1 N. A. N. A. Approved [259]
Hydralazine DMU8JGH Chronic heart failure BD1Z Approved [597]
Methamphetamine DMPM4SK Anxiety Approved [598]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [599]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Catalase (CAT)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [600]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [601]
Haloperidol DM96SE0 Delirium Approved [14]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [602]
Selenium DM25CGV N. A. N. A. Approved [603]
Methimazole DM25FL8 Hyperthyroidism 5A02 Approved [604]
Citalopram DM2G9AE Acute coronary syndrome BA41 Approved [605]
Methotrexate DM2TEOL Anterior urethra cancer Approved [214]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [606]
Quercetin DM3NC4M Obesity 5B81 Approved [136]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [607]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [573]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [435]
Quercetin DM3NC4M Obesity 5B81 Approved [136]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [251]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [307]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [278]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [382]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [376]
Arsenic DMTL2Y1 N. A. N. A. Approved [259]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Dachshund homolog 1 (DACH1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [364]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [278]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [267]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [408]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [608]
Napabucasin DMDZ6Q3 Colorectal cancer 2B91.Z Phase 3 [609]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [248]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [254]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [610]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Panobinostat DM58WKG Chronic graft versus host disease Approved [248]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [307]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [141]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [285]
Urethane DM7NSI0 N. A. N. A. Phase 4 [551]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [611]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [254]
THAPSIGARGIN DMDMQIE N. A. N. A. Preclinical [612]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [613]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [255]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Halothane DM80OZ5 Anaesthesia 9A78.6 Approved [14]
Isoniazid DM5JVS3 Latent tuberculosis infection Approved [614]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [615]
Primidone DM0WX6I Epilepsy 8A60-8A68 Approved [14]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [14]
Cocaine DMSOX7I Anaesthesia 9A78.6 Approved [14]
Gefitinib DM15F0X Colon adenocarcinoma Approved [616]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [617]
Lapatinib DM3BH1Y Breast cancer 2C60-2C65 Approved [616]
Crizotinib DM4F29C Non-small-cell lung cancer 2C25.Y Approved [616]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [134]
Selenium DM25CGV N. A. N. A. Approved [195]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [208]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [618]
Leflunomide DMR8ONJ Arthritis FA20 Approved [262]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [141]
Gemfibrozil DMD8Q3J Hyperlipidaemia 5C80 Approved [619]
Fenofibrate DMFKXDY Coronary atherosclerosis Approved [619]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [504]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [251]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [415]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [413]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [394]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [285]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [620]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [439]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [621]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [441]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Glucosamine DM4ZLFD Osteoarthritis FA00-FA05 Approved [622]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [282]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [252]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [240]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [623]
Malathion DMXZ84M Pediculus capitis infestation 1G00.0 Approved [624]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [428]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [254]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [255]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [136]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [251]
Leflunomide DMR8ONJ Arthritis FA20 Approved [262]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [307]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [141]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [258]
Ethanol DMDRQZU Chronic pain MG30 Approved [264]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [504]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [408]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [181]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Glutathione hydrolase 7 (GGT7)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [141]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [285]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [377]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [261]
Primidone DM0WX6I Epilepsy 8A60-8A68 Approved [14]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [625]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [254]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [442]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [626]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [627]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [140]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [141]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [258]
Folic Acid DMEMBJC Colorectal carcinoma Approved [468]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [394]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [285]
Arsenic DMTL2Y1 N. A. N. A. Approved [259]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [240]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [583]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [628]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cytochrome P450 2D6 (CYP2D6)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [629]
Paliperidone DM7NPJS Psychotic disorder 6A20-6A25 Approved [630]
Dopamine DMPGUCF Acromegaly 5A60.0 Approved [631]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [632]
Oxatomide DM1F42Z Hay fever CA08.00 Approved [633]
Cinacalcet DMCX0K3 Hyperparathyroidism 5A51 Approved [634]
Capsaicin DMGMF6V Back pain ME84.Z Approved [161]
Pentamidine DMHZJCG African trypanosomiasis 1F51 Approved [123]
Quinidine DMLPICK N. A. N. A. Approved [635]
Buprenorphine DMPRI8G Opioid dependence 6C43.2Z Approved [636]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Sodium channel unspecific (NaC) TTRK8B9 NOUNIPROTAC Blocker [3]

Drug Transporter (DTP)
DTP Name DTP ID UniProt ID MOA REF
Multidrug resistance-associated protein 2 (ABCC2) DTFI42L MRP2_HUMAN Substrate [4]
Multidrug resistance-associated protein 1 (ABCC1) DTSYQGK MRP1_HUMAN Substrate [5]
P-glycoprotein 1 (ABCB1) DTUGYRD MDR1_HUMAN Substrate [6]

Drug-Metabolizing Enzyme (DME)
DME Name DME ID UniProt ID MOA REF
Cytochrome P450 3A4 (CYP3A4) DE4LYSA CP3A4_HUMAN Substrate [7]
Cytochrome P450 2C9 (CYP2C9) Main DME DE5IED8 CP2C9_HUMAN Substrate [8]
Glutathione S-transferase alpha-1 (GSTA1) DE4ZHS1 GSTA1_HUMAN Substrate [9]
Mephenytoin 4-hydroxylase (CYP2C19) Main DME DEGTFWK CP2CJ_HUMAN Substrate [10]
Cytochrome P450 3A5 (CYP3A5) DEIBDNY CP3A5_HUMAN Substrate [11]
Cytochrome P450 2B6 (CYP2B6) DEPKLMQ CP2B6_HUMAN Substrate [11]
Cytochrome P450 2C8 (CYP2C8) DES5XRU CP2C8_HUMAN Substrate [10]
Cytochrome P450 3A7 (CYP3A7) DERD86B CP3A7_HUMAN Substrate [11]
Cytochrome P450 2C18 (CYP2C18) DEZMWRE CP2CI_HUMAN Substrate [10]

Drug Off-Target (DOT)
DOT Name DOT ID UniProt ID Interaction REF
72 kDa type IV collagenase (MMP2) OT5NIWA2 MMP2_HUMAN Gene/Protein Processing [12]
A disintegrin and metalloproteinase with thrombospondin motifs 20 (ADAMTS20) OTU0EKLN ATS20_HUMAN Drug Response [13]
Adiponectin receptor protein 2 (ADIPOR2) OT2HDTL8 PAQR2_HUMAN Drug Response [13]
Alanine aminotransferase 1 (GPT) OTOXOA0Q ALAT1_HUMAN Drug Response [14]
Alkaline phosphatase, tissue-nonspecific isozyme (ALPL) OTG7J4BP PPBT_HUMAN Drug Response [14]
Alpha-fetoprotein (AFP) OT9GG3ZI FETA_HUMAN Gene/Protein Processing [15]
Angiotensin-converting enzyme 2 (ACE2) OTTRZGU7 ACE2_HUMAN Gene/Protein Processing [16]
Annexin A4 (ANXA4) OTUCRYXL ANXA4_HUMAN Gene/Protein Processing [15]
Aromatase (CYP19A1) OTZ6XF74 CP19A_HUMAN Gene/Protein Processing [17]
ATP-binding cassette sub-family C member 2 (ABCC2) OTJSIGV5 MRP2_HUMAN Drug Response [18]

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2 Phenytoin FDA Label
3 Lacosamide: a new approach to target voltage-gated sodium currents in epileptic disorders. CNS Drugs. 2009;23(7):555-68.
4 Upregulation of brain expression of P-glycoprotein in MRP2-deficient TR(-) rats resembles seizure-induced up-regulation of this drug efflux transporter in normal rats. Epilepsia. 2007 Apr;48(4):631-45.
5 Evaluation of transport of common antiepileptic drugs by human multidrug resistance-associated proteins (MRP1, 2 and 5) that are overexpressed in pharmacoresistant epilepsy. Neuropharmacology. 2010 Jun;58(7):1019-32.
6 The transport of antiepileptic drugs by P-glycoprotein. Adv Drug Deliv Rev. 2012 Jul;64(10):930-42.
7 Coadministration of lopinavir/ritonavir and phenytoin results in two-way drug interaction through cytochrome P-450 induction. J Acquir Immune Defic Syndr. 2004 Aug 15;36(5):1034-40.
8 Antiepileptic drug interactions - principles and clinical implications. Curr Neuropharmacol. 2010 Sep;8(3):254-67.
9 Comparison of basal glutathione S-transferase activities and of the influence of phenobarbital, butylated hydroxy-anisole or 5,5'-diphenylhydantoin on enzyme activity in male rodents. Comp Biochem Physiol C. 1987;88(1):91-3.
10 Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev. 2002 Feb-May;34(1-2):83-448.
11 PharmGKB summary: phenytoin pathway. Pharmacogenet Genomics. 2012 Jun;22(6):466-70.
12 Impaired degradation of matrix collagen in human gingival fibroblasts by the antiepileptic drug phenytoin. J Periodontol. 2005 Jun;76(6):941-50. doi: 10.1902/jop.2005.76.6.941.
13 Genome-wide mapping for clinically relevant predictors of lamotrigine- and phenytoin-induced hypersensitivity reactions. Pharmacogenomics. 2012 Mar;13(4):399-405. doi: 10.2217/pgs.11.165.
14 ADReCS-Target: target profiles for aiding drug safety research and application. Nucleic Acids Res. 2018 Jan 4;46(D1):D911-D917. doi: 10.1093/nar/gkx899.
15 Role of phenytoin in wound healing: microarray analysis of early transcriptional responses in human dermal fibroblasts. Biochem Biophys Res Commun. 2004 Feb 13;314(3):661-6. doi: 10.1016/j.bbrc.2003.12.146.
16 Effect of common medications on the expression of SARS-CoV-2 entry receptors in liver tissue. Arch Toxicol. 2020 Dec;94(12):4037-4041. doi: 10.1007/s00204-020-02869-1. Epub 2020 Aug 17.
17 Inhibition of human aromatase complex (CYP19) by antiepileptic drugs. Toxicol In Vitro. 2008 Feb;22(1):146-53.
18 Intestinal expression of cytochrome P450 enzymes and ABC transporters and carbamazepine and phenytoin disposition. Acta Neurol Scand. 2007 Apr;115(4):232-42. doi: 10.1111/j.1600-0404.2006.00761.x.
19 Sidedness of carbamazepine accessibility to voltage-gated sodium channels. Mol Pharmacol. 2014 Feb;85(2):381-7.
20 Antiepileptic drugs and relapse after epilepsy surgery. Epileptic Disord. 2008 Sep;10(3):193-8.
21 Progress report on new antiepileptic drugs: a summary of the Ninth Eilat Conference (EILAT IX). Epilepsy Res. 2009 Jan;83(1):1-43.
22 Synthesis and pharmacological evaluation of phenylacetamides as sodium-channel blockers. J Med Chem. 1994 Jan 21;37(2):268-74.
23 Medicinal chemistry of neuronal voltage-gated sodium channel blockers. J Med Chem. 2001 Jan 18;44(2):115-37.
24 Block of neuronal tetrodotoxin-resistant Na+ currents by stereoisomers of piperidine local anesthetics. Anesth Analg. 2000 Dec;91(6):1499-505.
25 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
26 In vitro assays for repellents and deterrents for ticks: differing effects of products when tested with attractant or arrestment stimuli. Med Vet Entomol. 2003 Dec;17(4):370-8.
27 Emerging drugs for epilepsy. Expert Opin Emerg Drugs. 2007 Sep;12(3):407-22.
28 WO patent application no. 2008,0857,11, Synergy of sodium channel blockers and calcium channel blockers.
29 The role of bioreductive activation of doxorubicin in cytotoxic activity against leukaemia HL60-sensitive cell line and its multidrug-resistant sublines. Br J Cancer. 2005 Jul 11;93(1):89-97.
30 Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport. Cancer Res. 2001 Oct 1;61(19):7225-32.
31 Folate concentration dependent transport activity of the Multidrug Resistance Protein 1 (ABCC1). Biochem Pharmacol. 2004 Apr 15;67(8):1541-8.
32 Hammerhead ribozyme against gamma-glutamylcysteine synthetase sensitizes human colonic cancer cells to cisplatin by down-regulating both the glutathione synthesis and the expression of multidrug resistance proteins. Cancer Gene Ther. 2001 Oct;8(10):803-14.
33 Multidrug resistance-associated protein-1 functional activity in Calu-3 cells. J Pharmacol Exp Ther. 2001 Sep;298(3):1199-205.
34 Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions. Pharm Res. 2013 Apr;30(4):996-1007.
35 ATP-Dependent efflux of CPT-11 and SN-38 by the multidrug resistance protein (MRP) and its inhibition by PAK-104P. Mol Pharmacol. 1999 May;55(5):921-8.
36 Structural determinants of substrate specificity differences between human multidrug resistance protein (MRP) 1 (ABCC1) and MRP3 (ABCC3). Drug Metab Dispos. 2008 Dec;36(12):2571-81.
37 Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export. Br J Cancer. 2000 Aug;83(3):375-83.
38 Involvement of the drug transporters p glycoprotein and multidrug resistance-associated protein Mrp2 in telithromycin transport. Antimicrob Agents Chemother. 2006 Jan;50(1):80-7.
39 Dose-dependent disposition of methotrexate in Abcc2 and Abcc3 gene knockout murine models. Drug Metab Dispos. 2011 Nov;39(11):2155-61.
40 Mammalian multidrug-resistance proteins (MRPs). Essays Biochem. 2011 Sep 7;50(1):179-207.
41 Enhancing chemosensitivity in oral squamous cell carcinoma by lentivirus vector-mediated RNA interference targeting EGFR and MRP2. Oncol Lett. 2016 Sep;12(3):2107-2114.
42 Multidrug resistance associated protein 2 mediates transport of prostaglandin E2. Liver Int. 2006 Apr;26(3):362-8.
43 Lentivirus-mediated RNAi silencing targeting ABCC2 increasing the sensitivity of a human nasopharyngeal carcinoma cell line against cisplatin. J Transl Med. 2008 Oct 4;6:55.
44 Effect of acetaminophen on expression and activity of rat liver multidrug resistance-associated protein 2 and P-glycoprotein. Biochem Pharmacol. 2004 Aug 15;68(4):791-8.
45 Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting. Am J Physiol Gastrointest Liver Physiol. 2009 Aug;297(2):G371-7.
46 Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT). Drug Metab Dispos. 2002 Apr;30(4):457-63.
47 Multidrug Resistance-Associated Protein 2 (MRP2) Mediated Transport of Oxaliplatin-Derived Platinum in Membrane Vesicles. PLoS One. 2015 Jul 1;10(7):e0130727.
48 MDR1 (ABCB1) G1199A (Ser400Asn) polymorphism alters transepithelial permeability and sensitivity to anticancer agents. Cancer Chemother Pharmacol. 2009 Jun;64(1):183-8.
49 Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade. Cancer Lett. 2016 Jan 1;370(1):153-64.
50 Folate transporter expression decreases in the human placenta throughout pregnancy and in pre-eclampsia. Pregnancy Hypertens. 2012 Apr;2(2):123-31.
51 Comparative studies on in vitro methods for evaluating in vivo function of MDR1 P-glycoprotein. Pharm Res. 2001 Dec;18(12):1660-8.
52 Antiestrogens and steroid hormones: substrates of the human P-glycoprotein. Biochem Pharmacol. 1994 Jul 19;48(2):287-92.
53 Association of genetic polymorphisms in the influx transporter SLCO1B3 and the efflux transporter ABCB1 with imatinib pharmacokinetics in patients with chronic myeloid leukemia. Ther Drug Monit. 2011 Apr;33(2):244-50.
54 Expression levels and activation of a PXR variant are directly related to drug resistance in osteosarcoma cell lines. Cancer. 2007 Mar 1;109(5):957-65.
55 Contribution of human hepatic cytochrome P450 isoforms to regioselective hydroxylation of steroid hormones. Xenobiotica. 1998 Jun;28(6):539-47.
56 Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6. J Pharmacol Exp Ther. 2004 Sep;310(3):1062-75.
57 Isoform-specific regulation of cytochromes P450 expression by estradiol and progesterone. Drug Metab Dispos. 2013 Feb;41(2):263-9.
58 Metabolic interactions between acetaminophen (paracetamol) and two flavonoids, luteolin and quercetin, through in-vitro inhibition studies. J Pharm Pharmacol. 2017 Dec;69(12):1762-1772.
59 Potent mechanism-based inhibition of CYP3A4 by imatinib explains its liability to interact with CYP3A4 substrates. Br J Pharmacol. 2012 Apr;165(8):2787-98.
60 Effects of morin on the pharmacokinetics of etoposide in rats. Biopharm Drug Dispos. 2007 Apr;28(3):151-6.
61 The metabolism of zidovudine by human liver microsomes in vitro: formation of 3'-amino-3'-deoxythymidine. Biochem Pharmacol. 1994 Jul 19;48(2):267-76.
62 Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675.
63 Role of glutathione S-transferase P1-1 in the cellular detoxification of cisplatin. Mol Cancer Ther. 2008 Oct;7(10):3247-55.
64 Human glutathione transferase A3-3, a highly efficient catalyst of double-bond isomerization in the biosynthetic pathway of steroid hormones. J Biol Chem. 2001 Aug 31;276(35):33061-5.
65 Retinoid X receptor alpha regulates the expression of glutathione s-transferase genes and modulates acetaminophen-glutathione conjugation in mouse liver. Mol Pharmacol. 2005 Dec;68(6):1590-6.
66 Characterization and formation of the glutathione conjugate of clofibric acid. Drug Metab Dispos. 1995 Jan;23(1):119-23.
67 In vitro characterization of the human biotransformation and CYP reaction phenotype of ET-743 (Yondelis, Trabectidin), a novel marine anti-cancer drug. Invest New Drugs. 2006 Jan;24(1):3-14.
68 Glutathione S-transferase M1 polymorphism: a risk factor for hepatic venoocclusive disease in bone marrow transplantation. Blood. 2004 Sep 1;104(5):1574-7.
69 Inhibition of glutathione S-transferases by antimalarial drugs possible implications for circumventing anticancer drug resistance. Int J Cancer. 2002 Feb 10;97(5):700-5.
70 Purification and biochemical properties of glutathione S-transferase from Lactuca sativa. J Biochem Mol Biol. 2005 Mar 31;38(2):232-7.
71 Combined glutathione-S-transferase M1 and T1 genetic polymorphism and tacrine hepatotoxicity. Clin Pharmacol Ther. 2000 Apr;67(4):432-7.
72 Metabolism of melphalan by rat liver microsomal glutathione S-transferase. Chem Biol Interact. 2005 Apr 15;152(2-3):101-6.
73 Drug related genetic polymorphisms affecting adverse reactions to methotrexate, vinblastine, doxorubicin and cisplatin in patients with urothelial cancer. J Urol. 2008 Dec;180(6):2389-95.
74 Human prostate CYP3A5: identification of a unique 5'-untranslated sequence and characterization of purified recombinant protein. Biochem Biophys Res Commun. 1999 Jul 14;260(3):676-81.
75 Polymorphisms in cytochrome P4503A5 (CYP3A5) may be associated with race and tumor characteristics, but not metabolism and side effects of tamoxifen in breast cancer patients. Cancer Lett. 2005 Jan 10;217(1):61-72.
76 Drug Interactions Flockhart Table
77 Induction of hepatic CYP2E1 by a subtoxic dose of acetaminophen in rats: increase in dichloromethane metabolism and carboxyhemoglobin elevation. Drug Metab Dispos. 2007 Oct;35(10):1754-8.
78 Urinary 6 beta-hydroxycortisol excretion in rheumatoid arthritis. Br J Rheumatol. 1997 Jan;36(1):54-8.
79 Clinical pharmacokinetics of imatinib. Clin Pharmacokinet. 2005;44(9):879-94.
80 Kinetics and regulation of cytochrome P450-mediated etoposide metabolism. Drug Metab Dispos. 2004 Sep;32(9):993-1000.
81 Differential mechanism-based inhibition of CYP3A4 and CYP3A5 by verapamil. Drug Metab Dispos. 2005 May;33(5):664-71.
82 The role of cytochrome P450 3A (CYP3A) isoform(s) in oxidative metabolism of testosterone and benzphetamine in human adult and fetal liver. J Steroid Biochem Mol Biol. 1993 Jan;44(1):61-7.
83 Prediction of cytochrome P450 3A inhibition by verapamil enantiomers and their metabolites. Drug Metab Dispos. 2004 Feb;32(2):259-66.
84 The role of human cytochrome P450 enzymes in the formation of 2-hydroxymetronidazole: CYP2A6 is the high affinity (low Km) catalyst. Drug Metab Dispos. 2013 Sep;41(9):1686-94.
85 Diclofenac and its derivatives as tools for studying human cytochromes P450 active sites: particular efficiency and regioselectivity of P450 2Cs. Biochemistry. 1999 Oct 26;38(43):14264-70.
86 Possible involvement of multiple human cytochrome P450 isoforms in the liver metabolism of propofol. Br J Anaesth. 1998 Jun;80(6):788-95.
87 Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites. Mol Pharmacol. 2000 Dec;58(6):1341-8.
88 Targeted antipeptide antibodies to cytochrome P450 2C18 based on epitope mapping of an inhibitory monoclonal antibody to P450 2C51. Arch Biochem Biophys. 1997 Feb 15;338(2):157-64.
89 Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes. Chem Res Toxicol. 1996 Mar;9(2):365-73.
90 CYP2C8/9 mediate dapsone N-hydroxylation at clinical concentrations of dapsone. Drug Metab Dispos. 2000 Aug;28(8):865-8.
91 Induction of CYP2C genes in human hepatocytes in primary culture. Drug Metab Dispos. 2001 Mar;29(3):242-51.
92 Development of a substrate-activity based approach to identify the major human liver P-450 catalysts of cyclophosphamide and ifosfamide activation based on cDNA-expressed activities and liver microsomal P-450 profiles. Drug Metab Dispos. 1999 Jun;27(6):655-66.
93 Roles of cytochromes P450 1A2, 2A6, and 2C8 in 5-fluorouracil formation from tegafur, an anticancer prodrug, in human liver microsomes. Drug Metab Dispos. 2000 Dec;28(12):1457-63.
94 Role of cytochrome P450 2C8 in drug metabolism and interactions. Pharmacol Rev. 2016 Jan;68(1):168-241.
95 Differential expression and function of CYP2C isoforms in human intestine and liver. Pharmacogenetics. 2003 Sep;13(9):565-75.
96 Analysis of human cytochrome P450 2C8 substrate specificity using a substrate pharmacophore and site-directed mutants. Biochemistry. 2004 Dec 14;43(49):15379-92.
97 Interaction of sorafenib and cytochrome P450 isoenzymes in patients with advanced melanoma: a phase I/II pharmacokinetic interaction study. Cancer Chemother Pharmacol. 2011 Nov;68(5):1111-8.
98 PharmGKB summary: mycophenolic acid pathway. Pharmacogenet Genomics. 2014 Jan;24(1):73-9.
99 Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes. Arch Biochem Biophys. 1997 Oct 1;346(1):161-9.
100 Tamoxifen inhibits cytochrome P450 2C9 activity in breast cancer patients. J Chemother. 2006 Aug;18(4):421-4.
101 Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. Endocrinology. 2003 Aug;144(8):3382-98.
102 Drug-drug interactions with imatinib: an observational study. Medicine (Baltimore). 2016 Oct;95(40):e5076.
103 Drug interactions with calcium channel blockers: possible involvement of metabolite-intermediate complexation with CYP3A. Drug Metab Dispos. 2000 Feb;28(2):125-30.
104 New insights into the structural features and functional relevance of human cytochrome P450 2C9. Part I. Curr Drug Metab. 2009 Dec;10(10):1075-126.
105 A potential role for the estrogen-metabolizing cytochrome P450 enzymes in human breast carcinogenesis. Breast Cancer Res Treat. 2003 Dec;82(3):191-7.
106 A mechanistic approach to antiepileptic drug interactions. Ann Pharmacother. 1998 May;32(5):554-63.
107 Effect of tamoxifen on the enzymatic activity of human cytochrome CYP2B6. J Pharmacol Exp Ther. 2002 Jun;301(3):945-52.
108 Hepatic metabolism of diclofenac: role of human CYP in the minor oxidative pathways. Biochem Pharmacol. 1999 Sep 1;58(5):787-96.
109 Insights into CYP2B6-mediated drug-drug interactions. Acta Pharm Sin B. 2016 Sep;6(5):413-425.
110 Drugs that may have potential CYP2B6 interactions.
111 Involvement of human cytochrome P450 2B6 in the omega- and 4-hydroxylation of the anesthetic agent propofol. Xenobiotica. 2007 Jul;37(7):717-24.
112 Nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-butanone metabolism by cytochrome P450 2B6. Drug Metab Dispos. 2005 Dec;33(12):1760-4.
113 Application of the relative activity factor approach in scaling from heterologously expressed cytochromes p450 to human liver microsomes: studies on amitriptyline as a model substrate. J Pharmacol Exp Ther. 2001 Apr;297(1):326-37.
114 High-dose rabeprazole/amoxicillin therapy as the second-line regimen after failure to eradicate H. pylori by triple therapy with the usual doses of a proton pump inhibitor, clarithromycin and amoxicillin. Hepatogastroenterology. 2003 Nov-Dec;50(54):2274-8.
115 Cytochrome P450 pharmacogenetics and cancer. Oncogene. 2006 Mar 13;25(11):1679-91.
116 CYP2C19*17 is associated with decreased breast cancer risk. Breast Cancer Res Treat. 2009 May;115(2):391-6.
117 Cytochromes of the P450 2C subfamily are the major enzymes involved in the O-demethylation of verapamil in humans. Naunyn Schmiedebergs Arch Pharmacol. 1995 Dec;353(1):116-21.
118 Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology. 2001 Feb;120(2):525-33.
119 The relative role of CYP3A4 and CYP3A5 in eplerenone metabolism. Toxicol Lett. 2019 Oct 15;315:9-13.
120 Characterization of the structural determinants required for potent mechanism-based inhibition of human cytochrome P450 1A1 by cannabidiol. Chem Biol Interact. 2014 May 25;215:62-8.
121 Retinoids activate the RXR/SXR-mediated pathway and induce the endogenous CYP3A4 activity in Huh7 human hepatoma cells. Toxicol Sci. 2006 Jul;92(1):51-60.
122 The novel azole R126638 is a selective inhibitor of ergosterol synthesis in Candida albicans, Trichophyton spp., and Microsporum canis. Antimicrob Agents Chemother. 2004 Sep;48(9):3272-8.
123 Application of higher throughput screening (HTS) inhibition assays to evaluate the interaction of antiparasitic drugs with cytochrome P450s. Drug Metab Dispos. 2001 Jan;29(1):30-5.
124 Cetirizine and loratadine-based antihistamines with 5-lipoxygenase inhibitory activity. Bioorg Med Chem Lett. 2004 Nov 15;14(22):5591-4.
125 Mechanism-based inactivation of CYP3A by HIV protease inhibitors. J Pharmacol Exp Ther. 2005 Feb;312(2):583-91.
126 Studies of the toxicological potential of capsinoids, XIII: inhibitory effects of capsaicin and capsinoids on cytochrome P450 3A4 in human liver microsomes. Int J Toxicol. 2010 Mar;29(2 Suppl):22S-6S.
127 Investigation of the effects of axitinib on the pharmacokinetics of loperamide and its main metabolite N-demethylated loperamide in rats by UPLC-MS/MS. Chem Biol Interact. 2019 Sep 1;310:108744. doi: 10.1016/j.cbi.2019.108744. Epub 2019 Jul 9.
128 Human glutathione S-transferase A (GSTA) family genes are regulated by steroidogenic factor 1 (SF-1) and are involved in steroidogenesis. FASEB J. 2013 Aug;27(8):3198-208. doi: 10.1096/fj.12-222745. Epub 2013 May 6.
129 Polymorphisms of drug-metabolizing enzymes (GST, CYP2B6 and CYP3A) affect the pharmacokinetics of thiotepa and tepa. Br J Clin Pharmacol. 2009 Jan;67(1):50-60. doi: 10.1111/j.1365-2125.2008.03321.x. Epub 2008 Nov 17.
130 Acetaminophen-induced hepatocyte injury: C2-ceramide and oltipraz intervention, hepatocyte nuclear factor 1 and glutathione S-transferase A1 changes. J Appl Toxicol. 2019 Dec;39(12):1640-1650. doi: 10.1002/jat.3881. Epub 2019 Aug 6.
131 Antineoplastic drug sensitivity of human MCF-7 breast cancer cells stably transfected with a human alpha class glutathione S-transferase gene. Cancer Res. 1991 Jan 15;51(2):587-94.
132 Establishment of cisplatin-resistant ovarian yolk sac tumor cells and investigation of the mechanism of cisplatin resistance using this cell line. Gynecol Obstet Invest. 2011;71(2):104-11. doi: 10.1159/000320744. Epub 2010 Dec 9.
133 Overexpression of glutathione S-transferase A1-1 in ECV 304 cells protects against busulfan mediated G2-arrest and induces tissue factor expression. Br J Pharmacol. 2002 Dec;137(7):1100-6. doi: 10.1038/sj.bjp.0704972.
134 Global gene expression analysis reveals differences in cellular responses to hydroxyl- and superoxide anion radical-induced oxidative stress in caco-2 cells. Toxicol Sci. 2010 Apr;114(2):193-203. doi: 10.1093/toxsci/kfp309. Epub 2009 Dec 31.
135 Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium. Arthritis Rheumatol. 2014 Jan;66(1):15-23.
136 Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Mutagenesis. 2011 Sep;26(5):593-604.
137 Contribution of CYP3A5 to hepatic and renal ifosfamide N-dechloroethylation. Drug Metab Dispos. 2005 Jul;33(7):1074-81. doi: 10.1124/dmd.104.002279. Epub 2005 Apr 8.
138 Use of mRNA expression to detect the induction of drug metabolising enzymes in rat and human hepatocytes. Toxicol Appl Pharmacol. 2009 Feb 15;235(1):86-96.
139 Induction of human cytochrome P450 3A enzymes in cultured placental cells by thalidomide and relevance to bioactivation and toxicity. J Toxicol Sci. 2017;42(3):343-348.
140 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
141 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
142 Induction of hepatic CYP3A enzymes by pregnancy-related hormones: studies in human hepatocytes and hepatic cell lines. Drug Metab Dispos. 2013 Feb;41(2):281-90.
143 Cytochrome P450 inhibition potential of new psychoactive substances of the tryptamine class. Toxicol Lett. 2016 Jan 22;241:82-94.
144 Transcriptional profiling suggests that Nevirapine and Ritonavir cause drug induced liver injury through distinct mechanisms in primary human hepatocytes. Chem Biol Interact. 2016 Aug 5;255:31-44.
145 Evaluation of gene induction of drug-metabolizing enzymes and transporters in primary culture of human hepatocytes using high-sensitivity real-time reverse transcription PCR. Yakugaku Zasshi. 2002 May;122(5):339-61.
146 Thalidomide increases human hepatic cytochrome P450 3A enzymes by direct activation of the pregnane X receptor. Chem Res Toxicol. 2014 Feb 17;27(2):304-308.
147 Identification of novel agonists by high-throughput screening and molecular modelling of human constitutive androstane receptor isoform 3. Arch Toxicol. 2019 Aug;93(8):2247-2264. doi: 10.1007/s00204-019-02495-6. Epub 2019 Jul 16.
148 Antimalarial artemisinin drugs induce cytochrome P450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor. Mol Pharmacol. 2005 Jun;67(6):1954-65.
149 Characterization of human cytochrome P450 induction by pesticides. Toxicology. 2012 Mar 29;294(1):17-26.
150 Species-specific mechanisms for cholesterol 7alpha-hydroxylase (CYP7A1) regulation by drugs and bile acids. Arch Biochem Biophys. 2005 Feb 1;434(1):75-85.
151 Pyrethroids: cytotoxicity and induction of CYP isoforms in human hepatocytes. Drug Metabol Drug Interact. 2008;23(3-4):211-36.
152 Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine. Clin Pharmacol Ther. 2006 Nov;80(5):440-456.
153 Retinoic acid and its 4-oxo metabolites are functionally active in human skin cells in vitro. J Invest Dermatol. 2005 Jul;125(1):143-53.
154 Human drug metabolism genes in parathion-and estrogen-treated breast cells. Int J Mol Med. 2007 Dec;20(6):875-81.
155 Dose- and time-dependent effects of phenobarbital on gene expression profiling in human hepatoma HepaRG cells. Toxicol Appl Pharmacol. 2009 Feb 1;234(3):345-60.
156 Variability of CYP3A7 expression in human fetal liver. J Pharmacol Exp Ther. 2005 Aug;314(2):626-35. doi: 10.1124/jpet.105.086504. Epub 2005 Apr 21.
157 Participation of CYP2C8 and CYP3A4 in the N-demethylation of imatinib in human hepatic microsomes. Br J Pharmacol. 2010 Nov;161(5):1059-69. doi: 10.1111/j.1476-5381.2010.00946.x.
158 Pharmacotoxicology of clinically-relevant concentrations of obeticholic acid in an organotypic human hepatocyte system. Toxicol In Vitro. 2017 Mar;39:93-103.
159 Selective suppressions of human CYP3A forms, CYP3A5 and CYP3A7, by troglitazone in HepG2 cells. Drug Metab Pharmacokinet. 2002;17(1):42-6.
160 Inhibition of cytochrome P450 enzymes participating in p-nitrophenol hydroxylation by drugs known as CYP2E1 inhibitors. Chem Biol Interact. 2004 Apr 15;147(3):331-40.
161 Effects of capsaicin and dihydrocapsaicin on human and rat liver microsomal CYP450 enzyme activities in vitro and in vivo. J Asian Nat Prod Res. 2012;14(4):382-95.
162 Stiripentol. Expert Opin Investig Drugs. 2005 Jul;14(7):905-11.
163 Characteristics of P388/VMDRC.04, a simple, sensitive model for studying P-glycoprotein antagonists. Cancer Res. 1994 Feb 1;54(3):730-7.
164 Michaelis-Menten kinetic analysis of drugs of abuse to estimate their affinity to human P-glycoprotein. Toxicol Lett. 2013 Feb 27;217(2):137-42. doi: 10.1016/j.toxlet.2012.12.012. Epub 2012 Dec 27.
165 Editor's Highlight: PlacentalDisposition and Effects of Crizotinib: An Ex Vivo Study in the Isolated Dual-Side Perfused Human Cotyledon. Toxicol Sci. 2017 Jun 1;157(2):500-509. doi: 10.1093/toxsci/kfx063.
166 Functional evaluation of polymorphisms in the human ABCB1 gene and the impact on clinical responses of antiepileptic drugs. Pharmacogenet Genomics. 2008 May;18(5):390-402. doi: 10.1097/FPC.0b013e3282f85e36.
167 Cepharanthine potently enhances the sensitivity of anticancer agents in K562 cells. Cancer Sci. 2005 Jun;96(6):372-6. doi: 10.1111/j.1349-7006.2005.00057.x.
168 Clinical pharmacokinetic monitoring of itraconazole is warranted in only a subset of patients. Ther Drug Monit. 2005 Jun;27(3):322-33. doi: 10.1097/01.ftd.0000150135.22645.ea.
169 Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein. Psychopharmacology (Berl). 2006 Sep;187(4):415-23. doi: 10.1007/s00213-006-0437-9. Epub 2006 Jun 30.
170 Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro. Haematologica. 2002 Feb;87(2):167-76.
171 Characterization of the ATPase activity of the Mr 170,000 to 180,000 membrane glycoprotein (P-glycoprotein) associated with multidrug resistance in K562/ADM cells. Cancer Res. 1988 Sep 1;48(17):4926-32.
172 Functional defect caused by the 4544G>A SNP in ABCC2: potential impact for drug cellular disposition. Pharmacogenet Genomics. 2011 Dec;21(12):884-93. doi: 10.1097/FPC.0b013e32834d672b.
173 Role of multidrug resistance protein 2 (MRP2, ABCC2) in alkylating agent detoxification: MRP2 potentiates glutathione S-transferase A1-1-mediated resistance to chlorambucil cytotoxicity. J Pharmacol Exp Ther. 2004 Jan;308(1):260-7. doi: 10.1124/jpet.103.057729. Epub 2003 Oct 20.
174 MRP2 (ABCC2) transports taxanes and confers paclitaxel resistance and both processes are stimulated by probenecid. Int J Cancer. 2005 Sep 20;116(5):824-9. doi: 10.1002/ijc.21013.
175 Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia. Cancer Sci. 2008 May;99(5):967-72.
176 Methotrexate normalizes up-regulated folate pathway genes in rheumatoid arthritis. Arthritis Rheum. 2013 Nov;65(11):2791-802.
177 In vitro study of transporters involved in intestinal absorption of inorganic arsenic. Chem Res Toxicol. 2012 Feb 20;25(2):446-53. doi: 10.1021/tx200491f. Epub 2012 Jan 26.
178 Potency of individual bile acids to regulate bile acid synthesis and transport genes in primary human hepatocyte cultures. Toxicol Sci. 2014 Oct;141(2):538-46. doi: 10.1093/toxsci/kfu151. Epub 2014 Jul 23.
179 Co-encapsulation of chrysophsin-1 and epirubicin in PEGylated liposomes circumvents multidrug resistance in HeLa cells. Chem Biol Interact. 2015 Dec 5;242:13-23. doi: 10.1016/j.cbi.2015.08.023. Epub 2015 Sep 1.
180 Evaluation of drug transporters' significance for multidrug resistance in head and neck squamous cell carcinoma. Head Neck. 2011 Jul;33(7):959-68. doi: 10.1002/hed.21559. Epub 2010 Aug 24.
181 Gene expression analysis of precision-cut human liver slices indicates stable expression of ADME-Tox related genes. Toxicol Appl Pharmacol. 2011 May 15;253(1):57-69.
182 Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations. Pharmacogenomics. 2008 Oct;9(10):1543-6. doi: 10.2217/14622416.9.10.1543.
183 HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):4134-9. doi: 10.1073/pnas.0409500102. Epub 2005 Mar 2.
184 Blood transcript immune signatures distinguish a subset of people with elevated serum ALT from others given acetaminophen. Clin Pharmacol Ther. 2016 Apr;99(4):432-41.
185 HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese. Epilepsia. 2013 Jul;54(7):1307-14. doi: 10.1111/epi.12217. Epub 2013 May 20.
186 Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis. Chem Res Toxicol. 2015 May 18;28(5):927-34. doi: 10.1021/tx5005248. Epub 2015 Apr 3.
187 Genetic variations in HLA-B region and hypersensitivity reactions to abacavir. Lancet. 2002 Mar 30;359(9312):1121-2. doi: 10.1016/S0140-6736(02)08158-8.
188 HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet. 2009 Jul;41(7):816-9. doi: 10.1038/ng.379. Epub 2009 May 31.
189 HLA alleles influence the clinical signature of amoxicillin-clavulanate hepatotoxicity. PLoS One. 2013 Jul 9;8(7):e68111. doi: 10.1371/journal.pone.0068111. Print 2013.
190 Hla-B alleles and lamotrigine-induced cutaneous adverse drug reactions in the Han Chinese population. Basic Clin Pharmacol Toxicol. 2011 Jul;109(1):42-6. doi: 10.1111/j.1742-7843.2011.00681.x. Epub 2011 Mar 16.
191 Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenet Genomics. 2006 Apr;16(4):297-306. doi: 10.1097/01.fpc.0000199500.46842.4a.
192 A study of HLA class I and class II 4-digit allele level in Stevens-Johnson syndrome and toxic epidermal necrolysis. Int J Immunogenet. 2011 Aug;38(4):303-9. doi: 10.1111/j.1744-313X.2011.01011.x. Epub 2011 May 4.
193 Ticlopidine-induced hepatotoxicity is associated with specific human leukocyte antigen genomic subtypes in Japanese patients: a preliminary case-control study. Pharmacogenomics J. 2008 Feb;8(1):29-33. doi: 10.1038/sj.tpj.6500442. Epub 2007 Mar 6.
194 Microarray analysis of H2O2-, HNE-, or tBH-treated ARPE-19 cells. Free Radic Biol Med. 2002 Nov 15;33(10):1419-32.
195 Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst. 2009 Mar 4;101(5):306-20.
196 Differential modulation of PI3-kinase/Akt pathway during all-trans retinoic acid- and Am80-induced HL-60 cell differentiation revealed by DNA microarray analysis. Biochem Pharmacol. 2004 Dec 1;68(11):2177-86.
197 Changes in gene expression profiles of multiple myeloma cells induced by arsenic trioxide (ATO): possible mechanisms to explain ATO resistance in vivo. Br J Haematol. 2005 Mar;128(5):636-44.
198 Cyclosporine A--induced oxidative stress in human renal mesangial cells: a role for ERK 1/2 MAPK signaling. Toxicol Sci. 2012 Mar;126(1):101-13.
199 The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1. Toxicol Appl Pharmacol. 2009 Feb 15;235(1):124-34.
200 HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. N Engl J Med. 2011 Mar 24;364(12):1134-43. doi: 10.1056/NEJMoa1013297.
201 Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans. Pharmacogenet Genomics. 2011 May;21(5):303-7. doi: 10.1097/FPC.0b013e32834282b8.
202 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
203 Cytochrome P450 1A1/2 induction by antiparasitic drugs: dose-dependent increase in ethoxyresorufin O-deethylase activity and mRNA caused by quinine, primaquine and albendazole in HepG2 cells. Eur J Clin Pharmacol. 2002 Nov;58(8):537-42.
204 Association of CYP1A1 and CYP1B1 inhibition in in vitro assays with drug-induced liver injury. J Toxicol Sci. 2021;46(4):167-176. doi: 10.2131/jts.46.167.
205 Anti-androgenic effect of 6-formylindolo[3,2-b]carbazole (FICZ) in LNCaP cells is mediated by the aryl hydrocarbon-androgen receptors cross-talk. Steroids. 2020 Jan;153:108508. doi: 10.1016/j.steroids.2019.108508. Epub 2019 Oct 3.
206 Pharmacologic profiling of human and rat cytochrome P450 1A1 and 1A2 induction and competition. Arch Toxicol. 2008 Dec;82(12):909-21.
207 Effect of CYP1A1 gene polymorphisms on estrogen metabolism and bone density. J Bone Miner Res. 2005 Feb;20(2):232-9. doi: 10.1359/JBMR.041110. Epub 2004 Nov 16.
208 Increased sensitivity for troglitazone-induced cytotoxicity using a human in vitro co-culture model. Toxicol In Vitro. 2009 Oct;23(7):1387-95.
209 Isoform-specific induction of a human aldo-keto reductase by polycyclic aromatic hydrocarbons (PAHs), electrophiles, and oxidative stress: implications for the alternative pathway of PAH activation catalyzed by human dihydrodiol dehydrogenase. Cancer Res. 1999 Feb 1;59(3):607-14.
210 Gene expression changes in human small airway epithelial cells exposed to Delta9-tetrahydrocannabinol. Toxicol Lett. 2005 Aug 14;158(2):95-107.
211 The metallohormone cadmium modulates AhR-associated gene expression in the small intestine of rats similar to ethinyl-estradiol. Arch Toxicol. 2013 Apr;87(4):633-43.
212 Evidence for a new human CYP1A1 regulation pathway involving PPAR-alpha and 2 PPRE sites. Gastroenterology. 2004 Nov;127(5):1436-45.
213 p53-R175H mutant gains new function in regulation of doxorubicin-induced apoptosis. Int J Cancer. 2005 Apr 10;114(3):331-6. doi: 10.1002/ijc.20818.
214 The contribution of methotrexate exposure and host factors on transcriptional variance in human liver. Toxicol Sci. 2007 Jun;97(2):582-94.
215 Azidothymidine and cisplatin increase p14ARF expression in OVCAR-3 ovarian cancer cell line. Toxicol Appl Pharmacol. 2006 Oct 1;216(1):89-97. doi: 10.1016/j.taap.2006.04.015. Epub 2006 May 19.
216 Quantitative analysis of gene expression changes in response to genotoxic compounds. Toxicol In Vitro. 2017 Mar;39:15-28. doi: 10.1016/j.tiv.2016.11.004. Epub 2016 Nov 5.
217 Induction of apoptosis by cidofovir in human papillomavirus (HPV)-positive cells. Oncol Res. 2000;12(9-10):397-408. doi: 10.3727/096504001108747855.
218 Gallic acid potentiates the apoptotic effect of paclitaxel and carboplatin via overexpression of Bax and P53 on the MCF-7 human breast cancer cell line. J Biochem Mol Toxicol. 2021 Feb;35(2):e22638. doi: 10.1002/jbt.22638. Epub 2020 Oct 1.
219 Regulation of human dUTPase gene expression and p53-mediated transcriptional repression in response to oxaliplatin-induced DNA damage. Nucleic Acids Res. 2009 Jan;37(1):78-95. doi: 10.1093/nar/gkn910. Epub 2008 Nov 16.
220 Role of miRNA in the regulation of cannabidiol-mediated apoptosis in neuroblastoma cells. Oncotarget. 2019 Jan 1;10(1):45-59. doi: 10.18632/oncotarget.26534. eCollection 2019 Jan 1.
221 Nitrogen Mustard Alkylates and Cross-Links p53 in Human Keratinocytes. Chem Res Toxicol. 2022 Apr 18;35(4):636-650. doi: 10.1021/acs.chemrestox.1c00420. Epub 2022 Mar 21.
222 Fulvestrant induces resistance by modulating GPER and CDK6 expression: implication of methyltransferases, deacetylases and the hSWI/SNF chromatin remodelling complex. Br J Cancer. 2013 Nov 12;109(10):2751-62. doi: 10.1038/bjc.2013.583. Epub 2013 Oct 29.
223 Screening of a chemical library reveals novel PXR-activating pharmacologic compounds. Toxicol Lett. 2015 Jan 5;232(1):193-202. doi: 10.1016/j.toxlet.2014.10.009. Epub 2014 Oct 16.
224 Induction of PXR-mediated metabolism by beta-carotene. Biochim Biophys Acta. 2005 May 30;1740(2):162-9. doi: 10.1016/j.bbadis.2004.11.013. Epub 2004 Dec 8.
225 Lignans, bacteriocides and organochlorine compounds activate the human pregnane X receptor (PXR). Toxicol Appl Pharmacol. 2005 Dec 1;209(2):123-33. doi: 10.1016/j.taap.2005.03.015.
226 Identification and validation of novel human pregnane X receptor activators among prescribed drugs via ligand-based virtual screening. Drug Metab Dispos. 2011 Feb;39(2):337-44. doi: 10.1124/dmd.110.035808. Epub 2010 Nov 10.
227 Identification of HMG-CoA reductase inhibitors as activators for human, mouse and rat constitutive androstane receptor. Drug Metab Dispos. 2005 Jul;33(7):924-9.
228 Acetylated deoxycholic (DCA) and cholic (CA) acids are potent ligands of pregnane X (PXR) receptor. Toxicol Lett. 2017 Jan 4;265:86-96.
229 Aromatase inhibition: translation into a successful therapeutic approach. Clin Cancer Res. 2005 Apr 15;11(8):2809-21. doi: 10.1158/1078-0432.CCR-04-2187.
230 Cannabidiol (CBD) but not tetrahydrocannabinol (THC) dysregulate in vitro decidualization of human endometrial stromal cells by disruption of estrogen signaling. Reprod Toxicol. 2020 Apr;93:75-82. doi: 10.1016/j.reprotox.2020.01.003. Epub 2020 Jan 14.
231 Effects of selective serotonin reuptake inhibitors on three sex steroids in two versions of the aromatase enzyme inhibition assay and in the H295R cell assay. Toxicol In Vitro. 2015 Oct;29(7):1729-35.
232 Arsenite and cadmium promote the development of mammary tumors. Carcinogenesis. 2020 Jul 14;41(7):1005-1014. doi: 10.1093/carcin/bgz176.
233 Synthesis and evaluation of (pyridylmethylene)tetrahydronaphthalenes/-indanes and structurally modified derivatives: potent and selective inhibitors of aldosterone synthase. J Med Chem. 2005 Mar 10;48(5):1563-75.
234 Comparative assessment of the inhibition of recombinant human CYP19 (aromatase) by azoles used in agriculture and as drugs for humans. Endocr Res. 2004 Aug;30(3):387-94.
235 Estrogen synthesis in human colon cancer epithelial cells. J Steroid Biochem Mol Biol. 1999 Dec 31;71(5-6):223-30.
236 Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: a re-evaluation of P450 isoform selectivity. Eur J Drug Metab Pharmacokinet. 2011 Mar;36(1):1-16.
237 Inhibition of CYP2E1 catalytic activity in vitro by S-adenosyl-L-methionine. Biochem Pharmacol. 2005 Apr 1;69(7):1081-93.
238 Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins. Cell Biol Toxicol. 2012 Apr;28(2):69-87.
239 An in vitro model of human acute ethanol exposure that incorporates CXCR3- and CXCR4-dependent recruitment of immune cells. Toxicol Sci. 2013 Mar;132(1):131-41.
240 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
241 Proteomic analysis of hepatic effects of phenobarbital in mice with humanized liver. Arch Toxicol. 2022 Oct;96(10):2739-2754. doi: 10.1007/s00204-022-03338-7. Epub 2022 Jul 26.
242 Antiepileptic drugs: impacts on human serum paraoxonase-1. J Biochem Mol Toxicol. 2017 Jun;31(6).
243 Beneficial effect of oleoylated lipids on paraoxonase 1: protection against oxidative inactivation and stabilization. Biochem J. 2003 Oct 15;375(Pt 2):275-85.
244 Serum paraoxonase activity before and after treatment of thyrotoxicosis. Clin Endocrinol (Oxf). 2004 Jan;60(1):75-80.
245 Effects of some antibiotics on paraoxonase from human serum in vitro and from mouse serum and liver in vivo. Biol Pharm Bull. 2006 Aug;29(8):1559-63.
246 Simvastatin modulates expression of the PON1 gene and increases serum paraoxonase: a role for sterol regulatory element-binding protein-2. Arterioscler Thromb Vasc Biol. 2003 Nov 1;23(11):2083-9. doi: 10.1161/01.ATV.0000096207.01487.36. Epub 2003 Sep 18.
247 Dietary polyphenols increase paraoxonase 1 gene expression by an aryl hydrocarbon receptor-dependent mechanism. Mol Cell Biol. 2004 Jun;24(12):5209-22.
248 A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol. 2015 Sep;89(9):1599-618.
249 Transcriptional regulation of human paraoxonase 1 by PXR and GR in human hepatoma cells. Toxicol In Vitro. 2015 Dec 25;30(1 Pt B):348-54.
250 Induction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirin. J Lipid Res. 2008 Oct;49(10):2142-8.
251 Development of a neural teratogenicity test based on human embryonic stem cells: response to retinoic acid exposure. Toxicol Sci. 2011 Dec;124(2):370-7.
252 Design principles of concentration-dependent transcriptome deviations in drug-exposed differentiating stem cells. Chem Res Toxicol. 2014 Mar 17;27(3):408-20.
253 Epigenetic changes in individuals with arsenicosis. Chem Res Toxicol. 2011 Feb 18;24(2):165-7. doi: 10.1021/tx1004419. Epub 2011 Feb 4.
254 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
255 From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. Arch Toxicol. 2014 Jul;88(7):1451-68.
256 Neurotoxicity and underlying cellular changes of 21 mitochondrial respiratory chain inhibitors. Arch Toxicol. 2021 Feb;95(2):591-615. doi: 10.1007/s00204-020-02970-5. Epub 2021 Jan 29.
257 Utilization of CDKN1A/p21 gene for class discrimination of DNA damage-induced clastogenicity. Toxicology. 2014 Jan 6;315:8-16. doi: 10.1016/j.tox.2013.10.009. Epub 2013 Nov 6.
258 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
259 Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes. Toxicol Sci. 2015 Jan;143(1):97-106. doi: 10.1093/toxsci/kfu210. Epub 2014 Oct 10.
260 Identification of novel low-dose bisphenol a targets in human foreskin fibroblast cells derived from hypospadias patients. PLoS One. 2012;7(5):e36711. doi: 10.1371/journal.pone.0036711. Epub 2012 May 4.
261 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
262 Endoplasmic reticulum stress and MAPK signaling pathway activation underlie leflunomide-induced toxicity in HepG2 Cells. Toxicology. 2017 Dec 1;392:11-21.
263 Integrative "-Omics" analysis in primary human hepatocytes unravels persistent mechanisms of cyclosporine A-induced cholestasis. Chem Res Toxicol. 2016 Dec 19;29(12):2164-2174.
264 Gene expression signatures after ethanol exposure in differentiating embryoid bodies. Toxicol In Vitro. 2018 Feb;46:66-76.
265 Mifepristone induced progesterone withdrawal reveals novel regulatory pathways in human endometrium. Mol Hum Reprod. 2007 Sep;13(9):641-54.
266 Transcriptomic analysis of untreated and drug-treated differentiated HepaRG cells over a 2-week period. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):27-35.
267 Temozolomide induces activation of Wnt/-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. Cell Biol Toxicol. 2020 Jun;36(3):273-278. doi: 10.1007/s10565-019-09502-7. Epub 2019 Nov 22.
268 DNA methylation inhibits p53-mediated survivin repression. Oncogene. 2009 May 14;28(19):2046-50. doi: 10.1038/onc.2009.62. Epub 2009 Apr 13.
269 Transcriptional profiling of testosterone-regulated genes in the skeletal muscle of human immunodeficiency virus-infected men experiencing weight loss. J Clin Endocrinol Metab. 2007 Jul;92(7):2793-802. doi: 10.1210/jc.2006-2722. Epub 2007 Apr 17.
270 Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta. Mol Biol Cell. 2004 Mar;15(3):1262-72. doi: 10.1091/mbc.e03-06-0360. Epub 2003 Dec 29.
271 Characterizing the genetic basis for nicotine induced cancer development: a transcriptome sequencing study. PLoS One. 2013 Jun 18;8(6):e67252.
272 Cytosine arabinoside induces ectoderm and inhibits mesoderm expression in human embryonic stem cells during multilineage differentiation. Br J Pharmacol. 2011 Apr;162(8):1743-56.
273 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.
274 Screening autism-associated environmental factors in differentiating human neural progenitors with fractional factorial design-based transcriptomics. Sci Rep. 2023 Jun 29;13(1):10519. doi: 10.1038/s41598-023-37488-0.
275 Temporal changes in gene expression in the skin of patients treated with isotretinoin provide insight into its mechanism of action. Dermatoendocrinol. 2009 May;1(3):177-87.
276 Drug-induced activation of SREBP-controlled lipogenic gene expression in CNS-related cell lines: marked differences between various antipsychotic drugs. BMC Neurosci. 2006 Oct 20;7:69.
277 The exosome-like vesicles derived from androgen exposed-prostate stromal cells promote epithelial cells proliferation and epithelial-mesenchymal transition. Toxicol Appl Pharmacol. 2021 Jan 15;411:115384. doi: 10.1016/j.taap.2020.115384. Epub 2020 Dec 25.
278 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
279 Exposure-based assessment of chemical teratogenicity using morphogenetic aggregates of human embryonic stem cells. Reprod Toxicol. 2020 Jan;91:74-91. doi: 10.1016/j.reprotox.2019.10.004. Epub 2019 Nov 8.
280 The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance. Chem Biol Interact. 2012 Jan 5;195(1):52-60.
281 Molecular characterization of a toxicological tipping point during human stem cell differentiation. Reprod Toxicol. 2020 Jan;91:1-13. doi: 10.1016/j.reprotox.2019.10.001. Epub 2019 Oct 7.
282 Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol. 2005 Nov;19(11):2685-95.
283 Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.
284 Neuronal and cardiac toxicity of pharmacological compounds identified through transcriptomic analysis of human pluripotent stem cell-derived embryoid bodies. Toxicol Appl Pharmacol. 2021 Dec 15;433:115792. doi: 10.1016/j.taap.2021.115792. Epub 2021 Nov 3.
285 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
286 Identification of novel gene targets and putative regulators of arsenic-associated DNA methylation in human urothelial cells and bladder cancer. Chem Res Toxicol. 2015 Jun 15;28(6):1144-55. doi: 10.1021/tx500393y. Epub 2015 Jun 3.
287 Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1. FASEB J. 2012 Apr;26(4):1535-48. doi: 10.1096/fj.11-198184. Epub 2011 Dec 23.
288 Discovery of molecular mechanisms of neuroprotection using cell-based bioassays and oligonucleotide arrays. Physiol Genomics. 2002 Oct 29;11(2):45-52. doi: 10.1152/physiolgenomics.00064.2002.
289 Inhibition of invasion and induction of apoptosis by selenium in human malignant brain tumour cells in vitro. Int J Oncol. 2007 May;30(5):1263-71.
290 Dietary supplementation with the anti-tumour promoter quercetin: its effects on matrix metalloproteinase gene regulation. Mutat Res. 2001 Sep 1;480-481:269-76. doi: 10.1016/s0027-5107(01)00184-1.
291 Arsenic trioxide (As2O3) inhibits invasion of HT1080 human fibrosarcoma cells: role of nuclear factor-kappaB and reactive oxygen species. J Cell Biochem. 2005 Aug 1;95(5):955-69. doi: 10.1002/jcb.20452.
292 Aspirin inhibits MMP-2 and MMP-9 expressions and activities through upregulation of PPARalpha/gamma and TIMP gene expressions in ox-LDL-stimulated macrophages derived from human monocytes. Pharmacology. 2009;83(1):18-25. doi: 10.1159/000166183. Epub 2008 Oct 30.
293 Acetaminophen-induced proliferation of estrogen-responsive breast cancer cells is associated with increases in c-myc RNA expression and NF-kappaB activity. Toxicol Sci. 2002 Apr;66(2):233-43. doi: 10.1093/toxsci/66.2.233.
294 Sertraline induces endoplasmic reticulum stress in hepatic cells. Toxicology. 2014 Aug 1;322:78-88. doi: 10.1016/j.tox.2014.05.007. Epub 2014 May 24.
295 Estrogen regulation in human breast cancer cells of new downstream gene targets involved in estrogen metabolism, cell proliferation and cell transformation. J Mol Endocrinol. 2004 Apr;32(2):397-414.
296 ZD1839 induces p15INK4b and causes G1 arrest by inhibiting the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway. Mol Cancer Ther. 2007 May;6(5):1579-87. doi: 10.1158/1535-7163.MCT-06-0814.
297 Arsenic suppresses gene expression in promyelocytic leukemia cells partly through Sp1 oxidation. Blood. 2005 Jul 1;106(1):304-10.
298 Selenite and selenomethionine promote HL-60 cell cycle progression. J Nutr. 2002 Apr;132(4):674-9. doi: 10.1093/jn/132.4.674.
299 Ribavirin augments doxorubicin's efficacy in human hepatocellular carcinoma through inhibiting doxorubicin-induced eIF4E activation. J Biochem Mol Toxicol. 2018 Jan;32(1). doi: 10.1002/jbt.22007. Epub 2017 Nov 7.
300 Combination small molecule MEK and PI3K inhibition enhances uveal melanoma cell death in a mutant GNAQ- and GNA11-dependent manner. Clin Cancer Res. 2012 Aug 15;18(16):4345-55. doi: 10.1158/1078-0432.CCR-11-3227. Epub 2012 Jun 25.
301 Novel detection and differential utilization of a c-myc transcriptional block in colon cancer chemoprevention. Cancer Res. 2002 Nov 1;62(21):6006-10.
302 Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1. Redox Biol. 2020 Jan;28:101321. doi: 10.1016/j.redox.2019.101321. Epub 2019 Sep 5.
303 Ramipril inhibits in vitro human mesangial cell proliferation and platelet-derived growth factor expression. Exp Nephrol. 1999 May-Jun;7(3):229-35. doi: 10.1159/000020606.
304 Simvastatin inhibits PDGF-induced DNA synthesis in human glomerular mesangial cells. Kidney Int. 1993 Sep;44(3):503-8. doi: 10.1038/ki.1993.274.
305 Alcohol and Cannabinoids Differentially Affect HIV Infection and Function of Human Monocyte-Derived Dendritic Cells (MDDC). Front Microbiol. 2015 Dec 22;6:1452. doi: 10.3389/fmicb.2015.01452. eCollection 2015.
306 Chemosensitization by STI571 targeting the platelet-derived growth factor/platelet-derived growth factor receptor-signaling pathway in the tumor progression and angiogenesis of gastric carcinoma. Cancer. 2005 May 1;103(9):1800-9. doi: 10.1002/cncr.20973.
307 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
308 Progesterone regulation of implantation-related genes: new insights into the role of oestrogen. Cell Mol Life Sci. 2007 Apr;64(7-8):1009-32.
309 Comparison of intermittent and continuous oral administration of calcitriol in dialysis patients: a randomized prospective trial. Nephron. 1994;67(1):48-53. doi: 10.1159/000187887.
310 Normalization of lithium-induced hypercalcemia and hyperparathyroidism with cinacalcet hydrochloride. Am J Kidney Dis. 2006 Nov;48(5):832-7. doi: 10.1053/j.ajkd.2006.07.019.
311 Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis. PLoS One. 2010 Dec 13;5(12):e15235. doi: 10.1371/journal.pone.0015235.
312 Molecular mechanism of action of bisphenol and bisphenol A mediated by oestrogen receptor alpha in growth and apoptosis of breast cancer cells. Br J Pharmacol. 2013 May;169(1):167-78.
313 Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets. Clin J Am Soc Nephrol. 2008 May;3(3):658-64. doi: 10.2215/CJN.04981107. Epub 2008 Feb 6.
314 Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism. Kidney Int. 2003 Apr;63(4):1483-90. doi: 10.1046/j.1523-1755.2003.00878.x.
315 A phase I study of the vitamin D analogue EB 1089 in patients with advanced breast and colorectal cancer. Br J Cancer. 1998 Jul;78(1):6-13. doi: 10.1038/bjc.1998.434.
316 Indomethacin and juglone inhibit inflammatory molecules to induce apoptosis in colon cancer cells. J Biochem Mol Toxicol. 2020 Feb;34(2):e22433. doi: 10.1002/jbt.22433. Epub 2020 Jan 9.
317 A cell impedance-based real-time in vitro assay to assess the toxicity of amphotericin B formulations. Toxicol Appl Pharmacol. 2017 Nov 1;334:18-23. doi: 10.1016/j.taap.2017.08.017. Epub 2017 Sep 1.
318 CBD Promotes Oral Ulcer Healing via Inhibiting CMPK2-Mediated Inflammasome. J Dent Res. 2022 Feb;101(2):206-215. doi: 10.1177/00220345211024528. Epub 2021 Jul 16.
319 Sertraline, an antidepressant, induces apoptosis in hepatic cells through the mitogen-activated protein kinase pathway. Toxicol Sci. 2014 Feb;137(2):404-15. doi: 10.1093/toxsci/kft254. Epub 2013 Nov 5.
320 Anti-inflammatory effects of the GABA(B) receptor agonist baclofen in allergic contact dermatitis. Exp Dermatol. 2010 Jul 1;19(7):661-6. doi: 10.1111/j.1600-0625.2010.01076.x. Epub 2010 Feb 25.
321 Frankincense myrrh attenuates hepatocellular carcinoma by regulating tumor blood vessel development through multiple epidermal growth factor receptor-mediated signaling pathways. World J Gastrointest Oncol. 2022 Feb 15;14(2):450-477. doi: 10.4251/wjgo.v14.i2.450.
322 Sulfasalazine unveils a contact-independent HSV-TK/ganciclovir gene therapy bystander effect in malignant gliomas. Int J Oncol. 2007 Jan;30(1):283-90.
323 Oxidative Stress Alters miRNA and Gene Expression Profiles in Villous First Trimester Trophoblasts. Biomed Res Int. 2015;2015:257090. doi: 10.1155/2015/257090. Epub 2015 Aug 3.
324 Investigation of in vitro odonto/osteogenic capacity of cannabidiol on human dental pulp cell. J Dent. 2021 Jun;109:103673. doi: 10.1016/j.jdent.2021.103673. Epub 2021 Apr 16.
325 Patterns of some extracellular matrix gene expression are similar in cells from cleft lip-palate patients and in human palatal fibroblasts exposed to diazepam in culture. Toxicology. 2009 Mar 4;257(1-2):10-6. doi: 10.1016/j.tox.2008.12.002. Epub 2008 Dec 9.
326 Beta-carotene and apocarotenals promote retinoid signaling in BEAS-2B human bronchioepithelial cells. Arch Biochem Biophys. 2006 Nov 1;455(1):48-60.
327 Protective effects of myricitrin against osteoporosis via reducing reactive oxygen species and bone-resorbing cytokines. Toxicol Appl Pharmacol. 2014 Nov 1;280(3):550-60.
328 Gene expression profiling of rheumatoid arthritis synovial cells treated with antirheumatic drugs. J Biomol Screen. 2007 Apr;12(3):328-40. doi: 10.1177/1087057107299261. Epub 2007 Mar 22.
329 Acinar cell-specific knockout of the PTHrP gene decreases the proinflammatory and profibrotic responses in pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2014 Sep 1;307(5):G533-49. doi: 10.1152/ajpgi.00428.2013. Epub 2014 Jul 17.
330 The effects of particulate wear debris, cytokines, and growth factors on the functions of MG-63 osteoblasts. J Bone Joint Surg Am. 2001 Feb;83(2):201-11. doi: 10.2106/00004623-200102000-00007.
331 Inhibition of systemic sclerosis dermal fibroblast type I collagen production and gene expression by simvastatin. Arthritis Rheum. 2006 Apr;54(4):1298-308. doi: 10.1002/art.21723.
332 Antifibrotic effects of quercetin in primary orbital fibroblasts and orbital fat tissue cultures of Graves' orbitopathy. Invest Ophthalmol Vis Sci. 2012 Aug 31;53(9):5921-9. doi: 10.1167/iovs.12-9646.
333 Notoginsenoside R1 inhibits TNF-alpha-induced fibronectin production in smooth muscle cells via the ROS/ERK pathway. Free Radic Biol Med. 2006 May 1;40(9):1664-74. doi: 10.1016/j.freeradbiomed.2006.01.003. Epub 2006 Jan 26.
334 Integrated assessment by multiple gene expression analysis of quercetin bioactivity on anticancer-related mechanisms in colon cancer cells in vitro. Eur J Nutr. 2005 Mar;44(3):143-56. doi: 10.1007/s00394-004-0503-1. Epub 2004 Apr 30.
335 Small Molecule Antipsychotic Aripiprazole Potentiates Ozone-Induced Inflammation in Airway Epithelium. Chem Res Toxicol. 2019 Oct 21;32(10):1997-2005. doi: 10.1021/acs.chemrestox.9b00149. Epub 2019 Sep 11.
336 Peroxisome proliferator-activated receptor-gamma ligands suppress fibronectin gene expression in human lung carcinoma cells: involvement of both CRE and Sp1. Am J Physiol Lung Cell Mol Physiol. 2005 Sep;289(3):L419-28. doi: 10.1152/ajplung.00002.2005. Epub 2005 May 20.
337 Retinoic acid remodels extracellular matrix (ECM) of cultured human fetal palate mesenchymal cells (hFPMCs) through down-regulation of TGF-/Smad signaling. Toxicol Lett. 2014 Mar 3;225(2):208-15. doi: 10.1016/j.toxlet.2013.12.013. Epub 2013 Dec 24.
338 Ethacrynic acid exhibits selective toxicity to chronic lymphocytic leukemia cells by inhibition of the Wnt/beta-catenin pathway. PLoS One. 2009 Dec 14;4(12):e8294. doi: 10.1371/journal.pone.0008294.
339 An approach to elucidate potential mechanism of renal toxicity of arsenic trioxide. Exp Hematol. 2007 Feb;35(2):252-62.
340 Survival of retinal pigment epithelium after exposure to prolonged oxidative injury: a detailed gene expression and cellular analysis. Invest Ophthalmol Vis Sci. 2004 Oct;45(10):3767-77.
341 Comparison of base-line and chemical-induced transcriptomic responses in HepaRG and RPTEC/TERT1 cells using TempO-Seq. Arch Toxicol. 2018 Aug;92(8):2517-2531.
342 Low-expressional IGF1 mediated methimazole-induced liver developmental toxicity in fetal mice. Toxicology. 2018 Sep 1;408:70-79. doi: 10.1016/j.tox.2018.07.004. Epub 2018 Jul 7.
343 Effect of simvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, on alpha-fetoprotein gene expression through interaction with the ras-mediated pathway. J Hepatol. 1999 May;30(5):904-10. doi: 10.1016/s0168-8278(99)80146-9.
344 Effects of chlorpromazine with and without UV irradiation on gene expression of HepG2 cells. Mutat Res. 2005 Aug 4;575(1-2):47-60. doi: 10.1016/j.mrfmmm.2005.03.002. Epub 2005 Apr 26.
345 Expression of AFP and STAT3 is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in AFP-producing gastric cancer cells. PLoS One. 2013;8(1):e54774. doi: 10.1371/journal.pone.0054774. Epub 2013 Jan 30.
346 Zoledronate dysregulates fatty acid metabolism in renal tubular epithelial cells to induce nephrotoxicity. Arch Toxicol. 2018 Jan;92(1):469-485.
347 Cannabidiol-induced transcriptomic changes and cellular senescence in human Sertoli cells. Toxicol Sci. 2023 Feb 17;191(2):227-238. doi: 10.1093/toxsci/kfac131.
348 Oxidative Stress-Protective and Anti-Melanogenic Effects of Loliolide and Ethanol Extract from Fresh Water Green Algae, Prasiola japonica. Int J Mol Sci. 2018 Sep 18;19(9):2825. doi: 10.3390/ijms19092825.
349 The effects of a novel synthetic retinoid, seletinoid G, on the expression of extracellular matrix proteins in aged human skin in vivo. Clin Chim Acta. 2005 Dec;362(1-2):161-9. doi: 10.1016/j.cccn.2005.06.016. Epub 2005 Aug 1.
350 Ciprofloxacin enhances the stimulation of matrix metalloproteinase 3 expression by interleukin-1beta in human tendon-derived cells. A potential mechanism of fluoroquinolone-induced tendinopathy. Arthritis Rheum. 2002 Nov;46(11):3034-40. doi: 10.1002/art.10617.
351 Functional gene expression profile underlying methotrexate-induced senescence in human colon cancer cells. Tumour Biol. 2011 Oct;32(5):965-76.
352 Simvastatin reduces MMP1 expression in human smooth muscle cells cultured on polymerized collagen by inhibiting Rac1 activation. Arterioscler Thromb Vasc Biol. 2007 May;27(5):1043-9. doi: 10.1161/ATVBAHA.107.139881. Epub 2007 Feb 15.
353 Quercetin inhibits matrix metalloproteinase-1 expression in human vascular endothelial cells through extracellular signal-regulated kinase. Arch Biochem Biophys. 2001 Jul 1;391(1):72-8. doi: 10.1006/abbi.2001.2402.
354 Rofecoxib regulates the expression of genes related to the matrix metalloproteinase pathway in humans: implication for the adverse effects of cyclooxygenase-2 inhibitors. Clin Pharmacol Ther. 2006 Apr;79(4):303-15. doi: 10.1016/j.clpt.2005.12.306.
355 Interaction between the aryl hydrocarbon receptor and retinoic acid pathways increases matrix metalloproteinase-1 expression in keratinocytes. J Biol Chem. 2004 Jun 11;279(24):25284-93. doi: 10.1074/jbc.M402168200. Epub 2004 Apr 9.
356 Retinoic acid receptor alpha amplifications and retinoic acid sensitivity in breast cancers. Clin Breast Cancer. 2013 Oct;13(5):401-8.
357 Atheroprotective effect of estriol and estrone sulfate on human vascular smooth muscle cells. J Steroid Biochem Mol Biol. 2000 Jan-Feb;72(1-2):71-8. doi: 10.1016/s0960-0760(99)00149-1.
358 Essential role of cell cycle regulatory genes p21 and p27 expression in inhibition of breast cancer cells by arsenic trioxide. Med Oncol. 2011 Dec;28(4):1225-54.
359 Cannabidiol Modulates the Immunophenotype and Inhibits the Activation of the Inflammasome in Human Gingival Mesenchymal Stem Cells. Front Physiol. 2016 Nov 24;7:559. doi: 10.3389/fphys.2016.00559. eCollection 2016.
360 Gene expression profiles with activation of the estrogen receptor alpha-selective estrogen receptor modulator complex in breast cancer cells expressing wild-type estrogen receptor. Cancer Res. 2002 Aug 1;62(15):4419-26.
361 Distinct genetic profile in peripheral blood mononuclear cells of psoriatic arthritis patients treated with methotrexate and TNF-inhibitors. Clin Rheumatol. 2014 Dec;33(12):1815-21. doi: 10.1007/s10067-014-2807-8. Epub 2014 Oct 24.
362 Simvastatin inactivates beta1-integrin and extracellular signal-related kinase signaling and inhibits cell proliferation in head and neck squamous cell carcinoma cells. Cancer Sci. 2007 Jun;98(6):890-9.
363 Non-nutritional sweeteners effects on endothelial vascular function. Toxicol In Vitro. 2020 Feb;62:104694. doi: 10.1016/j.tiv.2019.104694. Epub 2019 Oct 23.
364 Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS One. 2013 May 28;8(5):e63862.
365 Regulation of epithelial cell morphology and functions approaching to more in vivo-like by modifying polyethylene glycol on polysulfone membranes. PLoS One. 2012;7(4):e36110.
366 Gene expression profile changes in NB4 cells induced by arsenic trioxide. Acta Pharmacol Sin. 2003 Jul;24(7):646-50.
367 Fanconi anemia links reactive oxygen species to insulin resistance and obesity. Antioxid Redox Signal. 2012 Oct 15;17(8):1083-98. doi: 10.1089/ars.2011.4417. Epub 2012 Jun 25.
368 [Testosterone's role in regulating expression of genes of several proliferation factors]. Tsitologiia. 2006;48(10):856-61.
369 Sulfasalazine and BAY 11-7082 interfere with the nuclear factor-kappa B and I kappa B kinase pathway to regulate the release of proinflammatory cytokines from human adipose tissue and skeletal muscle in vitro. Endocrinology. 2005 Mar;146(3):1491-7. doi: 10.1210/en.2004-0809. Epub 2004 Nov 24.
370 Methamphetamine exposure upregulates the amyloid precursor protein and hyperphosphorylated tau expression: The roles of insulin signaling in SH-SY5Y cell line. J Toxicol Sci. 2019;44(7):493-503. doi: 10.2131/jts.44.493.
371 Drug-induced endoplasmic reticulum and oxidative stress responses independently sensitize toward TNF-mediated hepatotoxicity. Toxicol Sci. 2014 Jul;140(1):144-59. doi: 10.1093/toxsci/kfu072. Epub 2014 Apr 20.
372 [Muscular damage during isotretinoin treatment]. Ann Dermatol Venereol. 1998 Feb;125(2):94-7.
373 Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety assessment. Arch Toxicol. 2016 Nov;90(11):2763-2777.
374 Elevation of creatine kinase from skeletal muscle associated with inhaled albuterol. Ann Allergy Asthma Immunol. 1996 Dec;77(6):488-90. doi: 10.1016/S1081-1206(10)63356-X.
375 Cell death mechanisms of the anti-cancer drug etoposide on human cardiomyocytes isolated from pluripotent stem cells. Arch Toxicol. 2018 Apr;92(4):1507-1524.
376 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
377 Predictive toxicology using systemic biology and liver microfluidic "on chip" approaches: application to acetaminophen injury. Toxicol Appl Pharmacol. 2012 Mar 15;259(3):270-80.
378 Myositis in association with carbimazole therapy. Lancet. 1989 Apr 29;1(8644):964. doi: 10.1016/s0140-6736(89)92550-6.
379 Comparative gene expression analysis of a chronic myelogenous leukemia cell line resistant to cyclophosphamide using oligonucleotide arrays and response to tyrosine kinase inhibitors. Leuk Res. 2007 Nov;31(11):1511-20.
380 Phenytoin and cyclosporin A suppress the expression of MMP-1, TIMP-1, and cathepsin L, but not cathepsin B in cultured gingival fibroblasts. J Periodontol. 2000 Jun;71(6):955-60. doi: 10.1902/jop.2000.71.6.955.
381 The antimalarial amodiaquine causes autophagic-lysosomal and proliferative blockade sensitizing human melanoma cells to starvation- and chemotherapy-induced cell death. Autophagy. 2013 Dec;9(12):2087-102. doi: 10.4161/auto.26506. Epub 2013 Oct 8.
382 A transcriptomics-based in vitro assay for predicting chemical genotoxicity in vivo. Carcinogenesis. 2012 Jul;33(7):1421-9.
383 A role for the autophagy regulator Transcription Factor EB in amiodarone-induced phospholipidosis. Biochem Pharmacol. 2015 Jun 1;95(3):201-9. doi: 10.1016/j.bcp.2015.03.017. Epub 2015 Apr 13.
384 Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2'-deoxycytidine treatment and oligonucleotide microarray. Cancer Sci. 2006 Jan;97(1):64-71.
385 Gingival Stromal Cells as an In Vitro Model: Cannabidiol Modulates Genes Linked With Amyotrophic Lateral Sclerosis. J Cell Biochem. 2017 Apr;118(4):819-828. doi: 10.1002/jcb.25757. Epub 2016 Nov 28.
386 Proton pump inhibitors interfere with the anti-tumor potency of RC48ADC. Toxicol In Vitro. 2022 Mar;79:105292. doi: 10.1016/j.tiv.2021.105292. Epub 2021 Dec 3.
387 Pyrimethamine induces apoptosis of melanoma cells via a caspase and cathepsin double-edged mechanism. Cancer Res. 2008 Jul 1;68(13):5291-300. doi: 10.1158/0008-5472.CAN-08-0222.
388 Synergistic effects of arsenic trioxide and silibinin on apoptosis and invasion in human glioblastoma U87MG cell line. Neurochem Res. 2012 Feb;37(2):370-80. doi: 10.1007/s11064-011-0620-1. Epub 2011 Oct 4.
389 Thyroid organotypic rat and human cultures used to investigate drug effects on thyroid function, hormone synthesis and release pathways. Toxicol Appl Pharmacol. 2012 Apr 1;260(1):81-8. doi: 10.1016/j.taap.2012.01.029. Epub 2012 Feb 8.
390 Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization. Autophagy. 2016 Nov;12(11):2213-2229. doi: 10.1080/15548627.2016.1213927. Epub 2016 Sep 16.
391 Identification of vitamin D3 target genes in human breast cancer tissue. J Steroid Biochem Mol Biol. 2016 Nov;164:90-97.
392 Modelling cardiac fibrosis using three-dimensional cardiac microtissues derived from human embryonic stem cells. J Biol Eng. 2019 Feb 13;13:15. doi: 10.1186/s13036-019-0139-6. eCollection 2019.
393 Primary Human Hepatocyte Spheroids as Tools to Study the Hepatotoxic Potential of Non-Pharmaceutical Chemicals. Int J Mol Sci. 2021 Oct 12;22(20):11005. doi: 10.3390/ijms222011005.
394 Identification of mechanisms of action of bisphenol a-induced human preadipocyte differentiation by transcriptional profiling. Obesity (Silver Spring). 2014 Nov;22(11):2333-43.
395 Impaired migration of trophoblast cells caused by simvastatin is associated with decreased membrane IGF-I receptor, MMP2 activity and HSP27 expression. Hum Reprod. 2007 Apr;22(4):1161-7. doi: 10.1093/humrep/del464. Epub 2006 Dec 11.
396 Quercetin Suppresses the Migration and Invasion in Human Colon Cancer Caco-2 Cells Through Regulating Toll-like Receptor 4/Nuclear Factor-kappa B Pathway. Pharmacogn Mag. 2016 May;12(Suppl 2):S237-44. doi: 10.4103/0973-1296.182154. Epub 2016 May 11.
397 Troglitazone but not conjugated linoleic acid reduces gene expression and activity of matrix-metalloproteinases-2 and -9 in PMA-differentiated THP-1 macrophages. J Nutr Biochem. 2008 Sep;19(9):594-603. doi: 10.1016/j.jnutbio.2007.08.003. Epub 2007 Dec 21.
398 Multifaceted suppression of aggressive behavior of thyroid carcinoma by all-trans retinoic acid induced re-differentiation. Mol Cell Endocrinol. 2012 Jan 2;348(1):260-9. doi: 10.1016/j.mce.2011.09.002. Epub 2011 Sep 6.
399 Repetitive nonlethal oxidant injury to retinal pigment epithelium decreased extracellular matrix turnover in vitro and induced sub-RPE deposits in vivo. Invest Ophthalmol Vis Sci. 2006 Sep;47(9):4098-112. doi: 10.1167/iovs.05-1230.
400 Unique signatures of stress-induced senescent human astrocytes. Exp Neurol. 2020 Dec;334:113466. doi: 10.1016/j.expneurol.2020.113466. Epub 2020 Sep 17.
401 Reduction of synovial sublining layer inflammation and proinflammatory cytokine expression in psoriatic arthritis treated with methotrexate. Arthritis Rheum. 2004 Oct;50(10):3286-95. doi: 10.1002/art.20518.
402 Quercetin inhibits IL-1-induced proliferation and production of MMPs, COX-2, and PGE2 by rheumatoid synovial fibroblast. Inflammation. 2012 Aug;35(4):1585-94. doi: 10.1007/s10753-012-9473-2.
403 MS4A3-HSP27 target pathway reveals potential for haematopoietic disorder treatment in alimentary toxic aleukia. Cell Biol Toxicol. 2023 Feb;39(1):201-216. doi: 10.1007/s10565-021-09639-4. Epub 2021 Sep 28.
404 Protein expression profiling identifies molecular targets of quercetin as a major dietary flavonoid in human colon cancer cells. Proteomics. 2004 Jul;4(7):2160-74.
405 Gene expression profile induced by arsenic trioxide in chronic lymphocytic leukemia cells reveals a central role for heme oxygenase-1 in apoptosis and regulation of matrix metalloproteinase-9. Oncotarget. 2016 Dec 13;7(50):83359-83377.
406 The differential cancer growth associated with anaesthetics in a cancer xenograft model of mice: mechanisms and implications of postoperative cancer recurrence. Cell Biol Toxicol. 2023 Aug;39(4):1561-1575. doi: 10.1007/s10565-022-09747-9. Epub 2022 Aug 12.
407 Mitochondrial proteomics investigation of a cellular model of impaired dopamine homeostasis, an early step in Parkinson's disease pathogenesis. Mol Biosyst. 2014 Jun;10(6):1332-44.
408 Low doses of cisplatin induce gene alterations, cell cycle arrest, and apoptosis in human promyelocytic leukemia cells. Biomark Insights. 2016 Aug 24;11:113-21.
409 Transcriptional profiling in the human prefrontal cortex: evidence for two activational states associated with cocaine abuse. Pharmacogenomics J. 2003;3(1):27-40.
410 Identification of biomarkers for the initiation of apoptosis in human preneoplastic colonocytes by proteome analysis. Int J Cancer. 2004 Mar 20;109(2):220-9. doi: 10.1002/ijc.11692.
411 Stem cell transcriptome responses and corresponding biomarkers that indicate the transition from adaptive responses to cytotoxicity. Chem Res Toxicol. 2017 Apr 17;30(4):905-922.
412 NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells. J Biol Chem. 2019 May 24;294(21):8543-8554. doi: 10.1074/jbc.RA118.006983. Epub 2019 Apr 2.
413 Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma. Cancer Res. 2023 Jan 18;83(2):181-194. doi: 10.1158/0008-5472.CAN-22-1029.
414 Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner. Genome Res. 2012 Nov;22(11):2153-62.
415 Expression profile analysis of colon cancer cells in response to sulindac or aspirin. Biochem Biophys Res Commun. 2002 Mar 29;292(2):498-512.
416 Single-cell Transcriptome Mapping Identifies Common and Cell-type Specific Genes Affected by Acute Delta9-tetrahydrocannabinol in Humans. Sci Rep. 2020 Feb 26;10(1):3450. doi: 10.1038/s41598-020-59827-1.
417 JunD is involved in the antiproliferative effect of Delta9-tetrahydrocannabinol on human breast cancer cells. Oncogene. 2008 Aug 28;27(37):5033-44.
418 Effects of 1alpha,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol Cancer. 2011 May 18;10:58.
419 Ouabain impairs cell migration, and invasion and alters gene expression of human osteosarcoma U-2 OS cells. Environ Toxicol. 2017 Nov;32(11):2400-2413. doi: 10.1002/tox.22453. Epub 2017 Aug 10.
420 Dasatinib reverses cancer-associated fibroblasts (CAFs) from primary lung carcinomas to a phenotype comparable to that of normal fibroblasts. Mol Cancer. 2010 Jun 27;9:168.
421 Bone marrow osteoblast damage by chemotherapeutic agents. PLoS One. 2012;7(2):e30758. doi: 10.1371/journal.pone.0030758. Epub 2012 Feb 17.
422 Arsenic alters transcriptional responses to Pseudomonas aeruginosa infection and decreases antimicrobial defense of human airway epithelial cells. Toxicol Appl Pharmacol. 2017 Sep 15;331:154-163.
423 Activation of fibroblast growth factor (FGF) receptors by recombinant human FGF-5. Oncogene. 1993 May;8(5):1311-6.
424 Influence of common and rare genetic variation on warfarin dose among African-Americans and European-Americans using the exome array. Pharmacogenomics. 2017 Jul;18(11):1059-1073. doi: 10.2217/pgs-2017-0046. Epub 2017 Jul 7.
425 Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations. Int J Cancer. 2006 Apr 1;118(7):1699-712. doi: 10.1002/ijc.21570.
426 A high concentration of genistein down-regulates activin A, Smad3 and other TGF-beta pathway genes in human uterine leiomyoma cells. Exp Mol Med. 2012 Apr 30;44(4):281-92.
427 Increased expression of fibroblast growth factors (FGFs) and their receptor by protamine and suramin on Kaposi's sarcoma-derived cells. Anticancer Res. 1993 Jul-Aug;13(4):887-90.
428 Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests. Arch Toxicol. 2017 Feb;91(2):839-864.
429 Rofecoxib modulates multiple gene expression pathways in a clinical model of acute inflammatory pain. Pain. 2007 Mar;128(1-2):136-47.
430 Evaluation of a human iPSC-derived BBB model for repeated dose toxicity testing with cyclosporine A as model compound. Toxicol In Vitro. 2021 Jun;73:105112. doi: 10.1016/j.tiv.2021.105112. Epub 2021 Feb 22.
431 CXCL14 downregulation in human keratinocytes is a potential biomarker for a novel in vitro skin sensitization test. Toxicol Appl Pharmacol. 2020 Jan 1;386:114828. doi: 10.1016/j.taap.2019.114828. Epub 2019 Nov 14.
432 Identification by automated screening of a small molecule that selectively eliminates neural stem cells derived from hESCs but not dopamine neurons. PLoS One. 2009 Sep 23;4(9):e7155.
433 Proteomic analysis of human adipose tissue after rosiglitazone treatment shows coordinated changes to promote glucose uptake. Obesity (Silver Spring). 2010 Jan;18(1):27-34. doi: 10.1038/oby.2009.208. Epub 2009 Jun 25.
434 Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell. 2009 Aug 21;138(4):645-659. doi: 10.1016/j.cell.2009.06.034. Epub 2009 Aug 13.
435 DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019 Oct 10;11(1):138. doi: 10.1186/s13148-019-0725-y.
436 Thyroid hormone responsive genes in cultured human fibroblasts. J Clin Endocrinol Metab. 2005 Feb;90(2):936-43.
437 The effect of DNA methylation inhibitor 5-Aza-2'-deoxycytidine on human endometrial stromal cells. Hum Reprod. 2010 Nov;25(11):2859-69.
438 The proapoptotic effect of zoledronic acid is independent of either the bone microenvironment or the intrinsic resistance to bortezomib of myeloma cells and is enhanced by the combination with arsenic trioxide. Exp Hematol. 2011 Jan;39(1):55-65.
439 Transcriptome and DNA methylome dynamics during triclosan-induced cardiomyocyte differentiation toxicity. Stem Cells Int. 2018 Oct 29;2018:8608327.
440 Expression profiling in squamous carcinoma cells reveals pleiotropic effects of vitamin D3 analog EB1089 signaling on cell proliferation, differentiation, and immune system regulation. Mol Endocrinol. 2002 Jun;16(6):1243-56.
441 Identification of a transcriptomic signature of food-relevant genotoxins in human HepaRG hepatocarcinoma cells. Food Chem Toxicol. 2020 Jun;140:111297. doi: 10.1016/j.fct.2020.111297. Epub 2020 Mar 28.
442 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.
443 THC exposure of human iPSC neurons impacts genes associated with neuropsychiatric disorders. Transl Psychiatry. 2018 Apr 25;8(1):89. doi: 10.1038/s41398-018-0137-3.
444 Toxicoproteomics reveals an effect of clozapine on autophagy in human liver spheroids. Toxicol Mech Methods. 2023 Jun;33(5):401-410. doi: 10.1080/15376516.2022.2156005. Epub 2022 Dec 19.
445 Antileishmanial drugs cause up-regulation of interferon-gamma receptor 1, not only in the monocytes of visceral leishmaniasis cases but also in cultured THP1 cells. Ann Trop Med Parasitol. 2003 Apr;97(3):245-57. doi: 10.1179/000349803235001714.
446 Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas. J Clin Oncol. 2006 Jan 10;24(2):274-87. doi: 10.1200/JCO.2005.02.9405. Epub 2005 Dec 19.
447 Ouabain induces apoptotic cell death in human prostate DU 145 cancer cells through DNA damage and TRAIL pathways. Environ Toxicol. 2019 Dec;34(12):1329-1339. doi: 10.1002/tox.22834. Epub 2019 Aug 21.
448 Disulfiram is a direct and potent inhibitor of human O6-methylguanine-DNA methyltransferase (MGMT) in brain tumor cells and mouse brain and markedly increases the alkylating DNA damage. Carcinogenesis. 2014 Mar;35(3):692-702. doi: 10.1093/carcin/bgt366. Epub 2013 Nov 5.
449 Induction of the DNA repair gene O6-methylguanine-DNA methyltransferase by dexamethasone in glioblastomas. J Neurosurg. 2004 Oct;101(4):659-63. doi: 10.3171/jns.2004.101.4.0659.
450 Pharmacokinetic, biochemical and clinical effects of dimethyltriazenoimidazole-4-carboxamide-bischloroethylnitrosourea combination therapy in patients with advanced breast cancer. Int J Cancer. 2003 Feb 20;103(5):686-92. doi: 10.1002/ijc.10849.
451 Transcriptional repression of O6-methylguanine DNA methyltransferase gene rendering cells hypersensitive to N,N'-bis(2-chloroethyl)-N-nitrosurea in camptothecin-resistant cells. Mol Pharmacol. 2008 Aug;74(2):517-26. doi: 10.1124/mol.107.043620. Epub 2008 May 20.
452 Effects of ciglitazone and troglitazone on the proliferation of human stomach cancer cells. World J Gastroenterol. 2009 Jan 21;15(3):310-20.
453 Endoplasmic reticulum stress contributes to arsenic trioxide-induced intrinsic apoptosis in human umbilical and bone marrow mesenchymal stem cells. Environ Toxicol. 2016 Mar;31(3):314-28.
454 Altered oxidative status and integrin expression in cyclosporine A-treated oral epithelial cells. Toxicol Mech Methods. 2015 Feb;25(2):98-104. doi: 10.3109/15376516.2014.990595. Epub 2015 Jan 22.
455 Dexamethasone and the inflammatory response in explants of human omental adipose tissue. Mol Cell Endocrinol. 2010 Feb 5;315(1-2):292-8.
456 DNA array analysis of the effects of aspirin on colon cancer cells: involvement of Rac1. Carcinogenesis. 2004 Jul;25(7):1293-8.
457 Identification of genes linked to gefitinib treatment in prostate cancer cell lines with or without resistance to androgen: a clue to application of gefitinib to hormone-resistant prostate cancer. Oncol Rep. 2006 Jun;15(6):1453-60.
458 The thioredoxin system mediates redox-induced cell death in human colon cancer cells: implications for the mechanism of action of anticancer agents. Cancer Res. 2008 Oct 15;68(20):8269-77. doi: 10.1158/0008-5472.CAN-08-2010.
459 Development of an alternative zebrafish model for drug-induced intestinal toxicity. J Appl Toxicol. 2018 Feb;38(2):259-273. doi: 10.1002/jat.3520. Epub 2017 Oct 13.
460 Response rate of fibrosarcoma cells to cytotoxic drugs on the expression level correlates to the therapeutic response rate of fibrosarcomas and is mediated by regulation of apoptotic pathways. BMC Cancer. 2005 Jul 7;5:74. doi: 10.1186/1471-2407-5-74.
461 Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes. Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2716-23.
462 Quercetin potentiates apoptosis by inhibiting nuclear factor-kappaB signaling in H460 lung cancer cells. Biol Pharm Bull. 2013;36(6):944-51. doi: 10.1248/bpb.b12-01004.
463 Constitutive gene expression predisposes morphogen-mediated cell fate responses of NT2/D1 and 27X-1 human embryonal carcinoma cells. Stem Cells. 2007 Mar;25(3):771-8. doi: 10.1634/stemcells.2006-0271. Epub 2006 Nov 30.
464 Apoptosis induced by piroxicam plus cisplatin combined treatment is triggered by p21 in mesothelioma. PLoS One. 2011;6(8):e23569.
465 Modulation of fibroblast growth factor receptor expression and signalling during retinoic acid-induced differentiation of Tera-2 teratocarcinoma cells. Biochem Biophys Res Commun. 1993 Feb 26;191(1):149-56. doi: 10.1006/bbrc.1993.1196.
466 Thalidomide and Its Analogs Differentially Target Fibroblast Growth Factor Receptors: Thalidomide Suppresses FGFR Gene Expression while Pomalidomide Dampens FGFR2 Activity. Chem Res Toxicol. 2019 Apr 15;32(4):589-602. doi: 10.1021/acs.chemrestox.8b00286. Epub 2019 Mar 15.
467 All-trans-retinoic acid inhibits collapsin response mediator protein-2 transcriptional activity during SH-SY5Y neuroblastoma cell differentiation. FEBS J. 2007 Jan;274(2):498-511. doi: 10.1111/j.1742-4658.2006.05597.x.
468 Folic acid supplementation dysregulates gene expression in lymphoblastoid cells--implications in nutrition. Biochem Biophys Res Commun. 2011 Sep 9;412(4):688-92. doi: 10.1016/j.bbrc.2011.08.027. Epub 2011 Aug 16.
469 The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate beta-catenin/TCF-4 signaling. Oncogene. 2001 Feb 1;20(5):645-53. doi: 10.1038/sj.onc.1204123.
470 Novel mechanism of cannabidiol-induced apoptosis in breast cancer cell lines. Breast. 2018 Oct;41:34-41. doi: 10.1016/j.breast.2018.06.009. Epub 2018 Jun 22.
471 -Carotene Induces Apoptosis in Human Esophageal Squamous Cell Carcinoma Cell Lines via the Cav-1/AKT/NF-B Signaling Pathway. J Biochem Mol Toxicol. 2016 Mar;30(3):148-57. doi: 10.1002/jbt.21773. Epub 2016 Jan 6.
472 Cross-talk between non-genomic and genomic signalling pathways--distinct effect profiles of environmental estrogens. Toxicol Appl Pharmacol. 2010 Jun 1;245(2):160-70. doi: 10.1016/j.taap.2010.02.015. Epub 2010 Mar 4.
473 Dasatinib (BMS-354825) selectively induces apoptosis in lung cancer cells dependent on epidermal growth factor receptor signaling for survival. Cancer Res. 2006 Jun 1;66(11):5542-8. doi: 10.1158/0008-5472.CAN-05-4620.
474 BMN 673 (talazoparib): A potent PARP inhibitor for triple negative breast cancer with different genetic profile. J Biochem Mol Toxicol. 2019 May;33(5):e22286. doi: 10.1002/jbt.22286. Epub 2019 Jan 23.
475 Resveratrol attenuates senescence of adipose-derived mesenchymal stem cells and restores their paracrine effects on promoting insulin secretion of INS-1 cells through Pim-1. Eur Rev Med Pharmacol Sci. 2016;20(6):1203-13.
476 Cell cycle effects of nonsteroidal anti-inflammatory drugs and enhanced growth inhibition in combination with gemcitabine in pancreatic carcinoma cells. J Pharmacol Exp Ther. 2001 Sep;298(3):976-85.
477 Neurokinin-1 receptor (NK1R) inhibition sensitizes APL cells to anti-tumor effect of arsenic trioxide via restriction of NF-B axis: Shedding new light on resistance to Aprepitant. Int J Biochem Cell Biol. 2018 Oct;103:105-114. doi: 10.1016/j.biocel.2018.08.010. Epub 2018 Aug 23.
478 ERE-independent ERalpha target genes differentially expressed in human breast tumors. Mol Cell Endocrinol. 2005 Dec 21;245(1-2):53-9. doi: 10.1016/j.mce.2005.10.003. Epub 2005 Nov 17.
479 Neuroprotective effects of glucomoringin-isothiocyanate against H(2)O(2)-Induced cytotoxicity in neuroblastoma (SH-SY5Y) cells. Neurotoxicology. 2019 Dec;75:89-104. doi: 10.1016/j.neuro.2019.09.008. Epub 2019 Sep 12.
480 Microtubules are required for NF-kappaB nuclear translocation in neuroblastoma IMR-32 cells: modulation by zinc. J Neurochem. 2006 Oct;99(2):402-15. doi: 10.1111/j.1471-4159.2006.04005.x.
481 Protein phosphatase 2A interacts with and directly dephosphorylates RelA. J Biol Chem. 2001 Dec 21;276(51):47828-33. doi: 10.1074/jbc.M106103200. Epub 2001 Oct 8.
482 Activation of nuclear factor-kappa B pathway by simvastatin and RhoA silencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells. Mol Pharmacol. 2008 Aug;74(2):476-84.
483 Prevention of deoxycholate-induced gastric apoptosis by aspirin: roles of NF-kappaB and PKC signaling. J Surg Res. 2008 Mar;145(1):66-73. doi: 10.1016/j.jss.2007.04.039. Epub 2007 Jul 20.
484 hiPSC-Based Model of Prenatal Exposure to Cannabinoids: Effect on Neuronal Differentiation. Front Mol Neurosci. 2020 Jul 6;13:119. doi: 10.3389/fnmol.2020.00119. eCollection 2020.
485 Epigenetic changes and disturbed neural development in a human embryonic stem cell-based model relating to the fetal valproate syndrome. Hum Mol Genet. 2012 Sep 15;21(18):4104-14. doi: 10.1093/hmg/dds239. Epub 2012 Jun 20.
486 Minimal peroxide exposure of neuronal cells induces multifaceted adaptive responses. PLoS One. 2010 Dec 17;5(12):e14352. doi: 10.1371/journal.pone.0014352.
487 Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells. Nat Commun. 2018 Aug 9;9(1):3069. doi: 10.1038/s41467-018-05402-2.
488 Lunasin, a novel seed peptide, sensitizes human breast cancer MDA-MB-231 cells to aspirin-arrested cell cycle and induced apoptosis. Chem Biol Interact. 2010 Jul 30;186(2):127-34. doi: 10.1016/j.cbi.2010.04.027. Epub 2010 May 21.
489 Extracellular ATP drives breast cancer cell migration and metastasis via S100A4 production by cancer cells and fibroblasts. Cancer Lett. 2018 Aug 28;430:1-10. doi: 10.1016/j.canlet.2018.04.043. Epub 2018 May 5.
490 Treatment with anticancer agents induces dysregulation of specific Wnt signaling pathways in human ovarian luteinized granulosa cells in vitro. Toxicol Sci. 2013 Nov;136(1):183-92. doi: 10.1093/toxsci/kft175. Epub 2013 Aug 16.
491 Progesterone increases csk homologous kinase in HMC-1560 human mast cells and reduces cell proliferation. J Cell Biochem. 2007 Dec 1;102(5):1271-80. doi: 10.1002/jcb.21357.
492 Cannabidiol upregulates melanogenesis through CB1 dependent pathway by activating p38 MAPK and p42/44 MAPK. Chem Biol Interact. 2017 Aug 1;273:107-114. doi: 10.1016/j.cbi.2017.06.005. Epub 2017 Jun 7.
493 Growth stimulation of human pulmonary adenocarcinoma cells and small airway epithelial cells by beta-carotene via activation of cAMP, PKA, CREB and ERK1/2. Int J Cancer. 2006 Mar 15;118(6):1370-80. doi: 10.1002/ijc.21537.
494 Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis. Toxicol Appl Pharmacol. 2014 Mar 1;275(2):176-81. doi: 10.1016/j.taap.2014.01.005. Epub 2014 Jan 17.
495 Inhibition of activator protein 1 by barbiturates is mediated by differential effects on mitogen-activated protein kinases and the small G proteins ras and rac-1. J Pharmacol Exp Ther. 2004 Dec;311(3):1232-40. doi: 10.1124/jpet.104.071332. Epub 2004 Jul 19.
496 Growth of hormone-dependent MCF-7 breast cancer cells is promoted by constitutive caveolin-1 whose expression is lost in an EGF-R-mediated manner during development of tamoxifen resistance. Breast Cancer Res Treat. 2010 Feb;119(3):575-91. doi: 10.1007/s10549-009-0355-8. Epub 2009 Mar 15.
497 Effect of histamine H1 receptor antagonists on TARC/CCL17 and MDC/CCL22 production from CD14+ cells induced by antigenic stimulation in vitro. Int Arch Allergy Immunol. 2011;155(1):38-51. doi: 10.1159/000318720. Epub 2010 Nov 25.
498 SIRT3 Mediates the Antioxidant Effect of Hydrogen Sulfide in Endothelial Cells. Antioxid Redox Signal. 2016 Feb 20;24(6):329-43. doi: 10.1089/ars.2015.6331. Epub 2015 Nov 10.
499 Downregulation of mitogen-activated protein kinases (MAPKs) in chronic ethanol-induced fatty liver. Toxicol Mech Methods. 2020 Jul;30(6):407-416. doi: 10.1080/15376516.2020.1747126. Epub 2020 Apr 1.
500 A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling. Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16657-62. doi: 10.1073/pnas.0707936104. Epub 2007 Oct 9.
501 The stent-eluting drugs sirolimus and paclitaxel suppress healing of the endothelium by induction of autophagy. Am J Pathol. 2009 Nov;175(5):2226-34.
502 Modulation of apoptosis in HaCaT keratinocytes via differential regulation of ERK signaling pathway by flavonoids. J Biol Chem. 2005 Sep 9;280(36):31498-507. doi: 10.1074/jbc.M505537200. Epub 2005 Jul 13.
503 Expression and mitogenic effect of fibroblast growth factor-9 in human endometriotic implant is regulated by aberrant production of estrogen. J Clin Endocrinol Metab. 2003 Nov;88(11):5547-54. doi: 10.1210/jc.2003-030597.
504 Interleukin-19 as a translational indicator of renal injury. Arch Toxicol. 2015 Jan;89(1):101-6.
505 Clinical determinants of response to irinotecan-based therapy derived from cell line models. Clin Cancer Res. 2008 Oct 15;14(20):6647-55.
506 Fibroblast growth factor-9 is an endometrial stromal growth factor. Endocrinology. 2002 Jul;143(7):2715-21. doi: 10.1210/endo.143.7.8900.
507 Expression Profiling of Human Pluripotent Stem Cell-Derived Cardiomyocytes Exposed to Doxorubicin-Integration and Visualization of Multi-Omics Data. Toxicol Sci. 2018 May 1;163(1):182-195. doi: 10.1093/toxsci/kfy012.
508 Proteomic analysis of the cellular response to a potent sensitiser unveils the dynamics of haptenation in living cells. Toxicology. 2020 Dec 1;445:152603. doi: 10.1016/j.tox.2020.152603. Epub 2020 Sep 28.
509 A comprehensive analysis of Wnt/beta-catenin signaling pathway-related genes and crosstalk pathways in the treatment of As2O3 in renal cancer. Ren Fail. 2018 Nov;40(1):331-339.
510 Zidovudine induces S-phase arrest and cell cycle gene expression changes in human cells. Mutagenesis. 2005 Mar;20(2):139-46. doi: 10.1093/mutage/gei019. Epub 2005 Mar 22.
511 Cannabidiol Activates Neuronal Precursor Genes in Human Gingival Mesenchymal Stromal Cells. J Cell Biochem. 2017 Jun;118(6):1531-1546. doi: 10.1002/jcb.25815. Epub 2016 Dec 29.
512 Leptomycin B reduces primary and acquired resistance of gefitinib in lung cancer cells. Toxicol Appl Pharmacol. 2017 Nov 15;335:16-27. doi: 10.1016/j.taap.2017.09.017. Epub 2017 Sep 21.
513 Gene expression after treatment with hydrogen peroxide, menadione, or t-butyl hydroperoxide in breast cancer cells. Cancer Res. 2002 Nov 1;62(21):6246-54.
514 Bexarotene activates the p53/p73 pathway in human cutaneous T-cell lymphoma. Br J Dermatol. 2009 Mar;160(3):519-26. doi: 10.1111/j.1365-2133.2008.08931.x. Epub 2008 Nov 25.
515 Glucocorticoids induce G1 arrest of lymphoblastic cells through retinoblastoma protein Rb1 dephosphorylation in childhood acute lymphoblastic leukemia in vivo. Cancer Biol Ther. 2004 May;3(5):470-6. doi: 10.4161/cbt.3.5.838. Epub 2004 May 9.
516 Ciprofloxacin mediated cell growth inhibition, S/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line. Clin Cancer Res. 2000 Mar;6(3):891-900.
517 Capsaicin promotes a more aggressive gene expression phenotype and invasiveness in null-TRPV1 urothelial cancer cells. Carcinogenesis. 2011 May;32(5):686-94. doi: 10.1093/carcin/bgr025. Epub 2011 Feb 10.
518 The molecular basis of genistein-induced mitotic arrest and exit of self-renewal in embryonal carcinoma and primary cancer cell lines. BMC Med Genomics. 2008 Oct 10;1:49.
519 Alternatives for the worse: Molecular insights into adverse effects of bisphenol a and substitutes during human adipocyte differentiation. Environ Int. 2021 Nov;156:106730. doi: 10.1016/j.envint.2021.106730. Epub 2021 Jun 27.
520 Keratinocyte-derived IL-36gama plays a role in hydroquinone-induced chemical leukoderma through inhibition of melanogenesis in human epidermal melanocytes. Arch Toxicol. 2019 Aug;93(8):2307-2320.
521 Folate deficiency in normal human fibroblasts leads to altered expression of genes primarily linked to cell signaling, the cytoskeleton and extracellular matrix. J Nutr Biochem. 2007 Aug;18(8):541-52. doi: 10.1016/j.jnutbio.2006.11.002. Epub 2007 Feb 22.
522 Oxidative stress modulates theophylline effects on steroid responsiveness. Biochem Biophys Res Commun. 2008 Dec 19;377(3):797-802.
523 Delta9-tetrahydrocannabinol inhibits cytotrophoblast cell proliferation and modulates gene transcription. Mol Hum Reprod. 2006 May;12(5):321-33. doi: 10.1093/molehr/gal036. Epub 2006 Apr 5.
524 Identification of biomarkers and outcomes of endocrine disruption in human ovarian cortex using In Vitro Models. Toxicology. 2023 Feb;485:153425. doi: 10.1016/j.tox.2023.153425. Epub 2023 Jan 5.
525 Identification of transcriptome signatures and biomarkers specific for potential developmental toxicants inhibiting human neural crest cell migration. Arch Toxicol. 2016 Jan;90(1):159-80.
526 Plasmatic concentration of organochlorine lindane acts as metabolic disruptors in HepG2 liver cell line by inducing mitochondrial disorder. Toxicol Appl Pharmacol. 2013 Oct 15;272(2):325-34.
527 Gene expression profiling of early primary biliary cirrhosis: possible insights into the mechanism of action of ursodeoxycholic acid. Liver Int. 2008 Aug;28(7):997-1010. doi: 10.1111/j.1478-3231.2008.01744.x. Epub 2008 Apr 15.
528 Repurposing L-menthol for systems medicine and cancer therapeutics? L-menthol induces apoptosis through caspase 10 and by suppressing HSP90. OMICS. 2016 Jan;20(1):53-64.
529 Rosiglitazone sensitizes MDA-MB-231 breast cancer cells to anti-tumour effects of tumour necrosis factor-alpha, CH11 and CYC202. Endocr Relat Cancer. 2007 Jun;14(2):305-15. doi: 10.1677/ERC-06-0003.
530 Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: a gene expression profiling study with implications for potential combination therapies. Leuk Res. 2008 Feb;32(2):275-85. doi: 10.1016/j.leukres.2007.05.024. Epub 2007 Jul 19.
531 Increased mitochondrial ROS formation by acetaminophen in human hepatic cells is associated with gene expression changes suggesting disruption of the mitochondrial electron transport chain. Toxicol Lett. 2015 Apr 16;234(2):139-50.
532 Bisphenol A and bisphenol S induce distinct transcriptional profiles in differentiating human primary preadipocytes. PLoS One. 2016 Sep 29;11(9):e0163318.
533 Dolutegravir Impairs Stem Cell-Based 3D Morphogenesis Models in a Manner Dependent on Dose and Timing of Exposure: An Implication for Its Developmental Toxicity. Toxicol Sci. 2021 Nov 24;184(2):191-203. doi: 10.1093/toxsci/kfab112.
534 Genomic and proteomic analysis of the effects of cannabinoids on normal human astrocytes. Brain Res. 2008 Jan 29;1191:1-11.
535 Effect of prenatal arsenic exposure on DNA methylation and leukocyte subpopulations in cord blood. Epigenetics. 2014 May;9(5):774-82. doi: 10.4161/epi.28153. Epub 2014 Feb 13.
536 Detection of gene expression alteration of myeloma cells treated with arsenic trioxide. Zhonghua Xue Ye Xue Za Zhi. 2005 Apr;26(4):209-13.
537 The MT1G Gene in LUHMES Neurons Is a Sensitive Biomarker of Neurotoxicity. Neurotox Res. 2020 Dec;38(4):967-978. doi: 10.1007/s12640-020-00272-3. Epub 2020 Sep 1.
538 Downregulation of glutathione S-transferase M1 protein in N-butyl-N-(4-hydroxybutyl)nitrosamine-induced mouse bladder carcinogenesis. Toxicol Appl Pharmacol. 2014 Sep 15;279(3):322-330.
539 Arsenic trioxide downregulates specificity protein (Sp) transcription factors and inhibits bladder cancer cell and tumor growth. Exp Cell Res. 2010 Aug 1;316(13):2174-88. doi: 10.1016/j.yexcr.2010.04.027. Epub 2010 May 8.
540 The activity of a novel mithramycin analog is related to its binding to DNA, cellular accumulation, and inhibition of Sp1-driven gene transcription. Chem Biol Interact. 2014 Aug 5;219:123-32. doi: 10.1016/j.cbi.2014.05.019. Epub 2014 Jun 4.
541 Nuclear and Mitochondrial DNA Methylation Patterns Induced by Valproic Acid in Human Hepatocytes. Chem Res Toxicol. 2017 Oct 16;30(10):1847-1854. doi: 10.1021/acs.chemrestox.7b00171. Epub 2017 Sep 13.
542 SP1 and SP3 mediate progesterone-dependent induction of the 17beta hydroxysteroid dehydrogenase type 2 gene in human endometrium. Biol Reprod. 2006 Oct;75(4):605-14.
543 Specificity protein 1 (sp1) oscillation is involved in copper homeostasis maintenance by regulating human high-affinity copper transporter 1 expression. Mol Pharmacol. 2012 Mar;81(3):455-64. doi: 10.1124/mol.111.076422. Epub 2011 Dec 15.
544 Transcriptional regulation of neutral sphingomyelinase 2 gene expression of a human breast cancer cell line, MCF-7, induced by the anti-cancer drug, daunorubicin. Biochim Biophys Acta. 2009 Nov-Dec;1789(11-12):681-90. doi: 10.1016/j.bbagrm.2009.08.006. Epub 2009 Aug 19.
545 Pharmacologic doses of ascorbic acid repress specificity protein (Sp) transcription factors and Sp-regulated genes in colon cancer cells. Nutr Cancer. 2011;63(7):1133-42. doi: 10.1080/01635581.2011.605984. Epub 2011 Sep 15.
546 Moving toward integrating gene expression profiling into high-throughput testing: a gene expression biomarker accurately predicts estrogen receptor alpha modulation in a microarray compendium. Toxicol Sci. 2016 May;151(1):88-103.
547 Nicotine stimulates urokinase-type plasminogen activator receptor expression and cell invasiveness through mitogen-activated protein kinase and reactive oxygen species signaling in ECV304 endothelial cells. Toxicol Appl Pharmacol. 2012 Mar 1;259(2):248-56. doi: 10.1016/j.taap.2012.01.002. Epub 2012 Jan 9.
548 Quercetin inhibits invasion, migration and signalling molecules involved in cell survival and proliferation of prostate cancer cell line (PC-3). Cell Biochem Funct. 2011 Mar;29(2):87-95. doi: 10.1002/cbf.1725. Epub 2011 Feb 9.
549 [Clinical study on the fibrinolytic activity in patients with acute promyelocytic leukemia]. Zhonghua Xue Ye Xue Za Zhi. 2009 Mar;30(3):145-9.
550 Aspirin upregulates expression of urokinase type plasminogen activator receptor (uPAR) gene in human colon cancer cells through AP1. Biochem Biophys Res Commun. 2006 Sep 22;348(2):618-27. doi: 10.1016/j.bbrc.2006.07.098. Epub 2006 Jul 28.
551 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
552 Comparison of the effects of metoclopramide and domperidone on HERG channels. Pharmacology. 2005 Apr;74(1):31-6. doi: 10.1159/000083234. Epub 2005 Jan 7.
553 Further insights into the effect of quinidine in short QT syndrome caused by a mutation in HERG. J Cardiovasc Electrophysiol. 2005 Jan;16(1):54-8. doi: 10.1046/j.1540-8167.2005.04470.x.
554 Automated tight seal electrophysiology for assessing the potential hERG liability of pharmaceutical compounds. Assay Drug Dev Technol. 2004 Oct;2(5):497-506. doi: 10.1089/adt.2004.2.497.
555 Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model. Toxicol Sci. 2013 Dec;136(2):581-94. doi: 10.1093/toxsci/kft205. Epub 2013 Sep 19.
556 Pharmacology of the short QT syndrome N588K-hERG K+ channel mutation: differential impact on selected class I and class III antiarrhythmic drugs. Br J Pharmacol. 2008 Nov;155(6):957-66. doi: 10.1038/bjp.2008.325. Epub 2008 Aug 25.
557 Comparison of HERG channel blocking effects of various beta-blockers-- implication for clinical strategy. Br J Pharmacol. 2006 Mar;147(6):642-52. doi: 10.1038/sj.bjp.0706508.
558 Inhibitory effects of the class III antiarrhythmic drug amiodarone on cloned HERG potassium channels. Naunyn Schmiedebergs Arch Pharmacol. 1999 Mar;359(3):212-9. doi: 10.1007/pl00005344.
559 Redox state dependency of HERGS631C channel pharmacology: relation to C-type inactivation. FEBS Lett. 2000 May 26;474(1):111-5. doi: 10.1016/s0014-5793(00)01586-6.
560 The potential effects of HECTD4 variants on fasting glucose and triglyceride levels in relation to prevalence of type 2 diabetes based on alcohol intake. Arch Toxicol. 2022 Sep;96(9):2487-2499. doi: 10.1007/s00204-022-03325-y. Epub 2022 Jun 17.
561 Antirheumatic drug response signatures in human chondrocytes: potential molecular targets to stimulate cartilage regeneration. Arthritis Res Ther. 2009;11(1):R15.
562 Bioactive terpenoids and flavonoids from Ginkgo biloba extract induce the expression of hepatic drug-metabolizing enzymes through pregnane X receptor, constitutive androstane receptor, and aryl hydrocarbon receptor-mediated pathways. Pharm Res. 2009 Apr;26(4):872-82.
563 Species-specific toxicity of diclofenac and troglitazone in primary human and rat hepatocytes. Chem Biol Interact. 2009 Apr 15;179(1):17-24.
564 Fetal bovine serum and human constitutive androstane receptor: evidence for activation of the SV23 splice variant by artemisinin, artemether, and arteether in a serum-free cell culture system. Toxicol Appl Pharmacol. 2014 Jun 1;277(2):221-30. doi: 10.1016/j.taap.2014.03.023. Epub 2014 Apr 12.
565 Constitutive androstane/active receptor is a target of retinoic acid receptor in humans. Biochem Pharmacol. 2010 Jul 1;80(1):129-35. doi: 10.1016/j.bcp.2010.02.023. Epub 2010 Mar 6.
566 Robustness testing and optimization of an adverse outcome pathway on cholestatic liver injury. Arch Toxicol. 2020 Apr;94(4):1151-1172. doi: 10.1007/s00204-020-02691-9. Epub 2020 Mar 10.
567 Expression and inducibility of cytochrome P450s (CYP1A1, 2B6, 2E1, 3A4) in human cord blood CD34(+) stem cell-derived differentiating neuronal cells. Toxicol Sci. 2012 Oct;129(2):392-410.
568 Agonistic effects of diverse xenobiotics on the constitutive androstane receptor as detected in a recombinant yeast-cell assay. Toxicol In Vitro. 2018 Feb;46:335-349. doi: 10.1016/j.tiv.2017.09.014. Epub 2017 Sep 18.
569 Teriflunomide is an indirect human constitutive androstane receptor (CAR) activator interacting with epidermal growth factor (EGF) signaling. Front Pharmacol. 2018 Oct 11;9:993.
570 Apoptotic signaling pathways induced by nitric oxide in human lymphoblastoid cells expressing wild-type or mutant p53. Cancer Res. 2004 May 1;64(9):3022-9. doi: 10.1158/0008-5472.can-03-1880.
571 Quercetin-mediated Mcl-1 and survivin downregulation restores TRAIL-induced apoptosis in non-Hodgkin's lymphoma B cells. Haematologica. 2012 Jan;97(1):38-46. doi: 10.3324/haematol.2011.046466. Epub 2011 Sep 20.
572 Arsenic trioxide promotes histone H3 phosphoacetylation at the chromatin of CASPASE-10 in acute promyelocytic leukemia cells. J Biol Chem. 2002 Dec 20;277(51):49504-10. doi: 10.1074/jbc.M207836200. Epub 2002 Oct 17.
573 Inhibitory effects of cannabidiol on voltage-dependent sodium currents. J Biol Chem. 2018 Oct 26;293(43):16546-16558. doi: 10.1074/jbc.RA118.004929. Epub 2018 Sep 14.
574 Selective Recognition of H3.1K36 Dimethylation/H4K16 Acetylation Facilitates the Regulation of All-trans-retinoic Acid (ATRA)-responsive Genes by Putative Chromatin Reader ZMYND8. J Biol Chem. 2016 Feb 5;291(6):2664-81. doi: 10.1074/jbc.M115.679985. Epub 2015 Dec 11.
575 Electrophysiological and pharmacological properties of the human brain type IIA Na+ channel expressed in a stable mammalian cell line. Pflugers Arch. 2001 Jan;441(4):425-33. doi: 10.1007/s004240000448.
576 Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma. Oncotarget. 2014 May 15;5(9):2355-71.
577 Polymorphisms of ACE2 gene are associated with essential hypertension and antihypertensive effects of Captopril in women. Clin Pharmacol Ther. 2007 Aug;82(2):187-96. doi: 10.1038/sj.clpt.6100214. Epub 2007 May 2.
578 Bisphenol A induces DSB-ATM-p53 signaling leading to cell cycle arrest, senescence, autophagy, stress response, and estrogen release in human fetal lung fibroblasts. Arch Toxicol. 2018 Apr;92(4):1453-1469.
579 Distinct TP73-DAPK2-ATG5 pathway involvement in ATO-mediated cell death versus ATRA-mediated autophagy responses in APL. J Leukoc Biol. 2017 Dec;102(6):1357-1370. doi: 10.1189/jlb.1A0317-132R. Epub 2017 Oct 4.
580 DNA methyltransferase inhibitor 5-aza-CdR enhances the radiosensitivity of gastric cancer cells. Cancer Sci. 2009 Jan;100(1):181-8. doi: 10.1111/j.1349-7006.2008.01004.x. Epub 2008 Nov 25.
581 Soy isoflavones exert differential effects on androgen responsive genes in LNCaP human prostate cancer cells. J Nutr. 2007 Apr;137(4):964-72.
582 Regulation of adiponectin receptors in hepatocytes by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Diabetologia. 2006 Jun;49(6):1303-10. doi: 10.1007/s00125-006-0228-1. Epub 2006 Apr 12.
583 Long-term estrogen exposure promotes carcinogen bioactivation, induces persistent changes in gene expression, and enhances the tumorigenicity of MCF-7 human breast cancer cells. Toxicol Appl Pharmacol. 2009 Nov 1;240(3):355-66.
584 Classification of heavy-metal toxicity by human DNA microarray analysis. Environ Sci Technol. 2007 May 15;41(10):3769-74.
585 Sp1 and Sp3 transcription factors regulate the basal expression of human microsomal epoxide hydrolase (EPHX1) through interaction with the E1b far upstream promoter. Gene. 2014 Feb 15;536(1):135-44. doi: 10.1016/j.gene.2013.11.053. Epub 2013 Dec 4.
586 The genomic response of a human uterine endometrial adenocarcinoma cell line to 17alpha-ethynyl estradiol. Toxicol Sci. 2009 Jan;107(1):40-55.
587 Hypermethylation of the nel-like 1 gene is a common and early event and is associated with poor prognosis in early-stage esophageal adenocarcinoma. Oncogene. 2007 Sep 20;26(43):6332-40. doi: 10.1038/sj.onc.1210461. Epub 2007 Apr 23.
588 Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans. Pharmacogenomics J. 2014 Feb;14(1):35-40. doi: 10.1038/tpj.2013.3. Epub 2013 Feb 12.
589 Dose- and time-dependent transcriptional response of Ishikawa cells exposed to genistein. Toxicol Sci. 2016 May;151(1):71-87.
590 Hydroxychloroquine decreases human MSC-derived osteoblast differentiation and mineralization in vitro. J Cell Mol Med. 2018 Feb;22(2):873-882. doi: 10.1111/jcmm.13373. Epub 2017 Oct 3.
591 Sensitivity of human dental pulp cells to eighteen chemical agents used for endodontic treatments in dentistry. Odontology. 2013 Jan;101(1):43-51.
592 Glucosamine promotes osteogenic differentiation of dental pulp stem cells through modulating the level of the transforming growth factor-beta type I receptor. J Cell Physiol. 2010 Oct;225(1):140-51.
593 A highly potent 26,27-Hexafluoro-1a,25-dihydroxyvitamin D3 on calcification in SV40-transformed human fetal osteoblastic cells. Calcif Tissue Int. 2002 Jun;70(6):488-95.
594 Novel pathways of endocrine disruption through pesticides interference with human mineralocorticoid receptors. Toxicol Sci. 2018 Mar 1;162(1):53-63.
595 Effect of aflatoxin B(1), benzo[a]pyrene, and methapyrilene on transcriptomic and epigenetic alterations in human liver HepaRG cells. Food Chem Toxicol. 2018 Nov;121:214-223. doi: 10.1016/j.fct.2018.08.034. Epub 2018 Aug 26.
596 Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicity. Int J Cancer. 2007 Jan 1;120(1):24-31. doi: 10.1002/ijc.22073.
597 A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes. BMC Cancer. 2005 Apr 29;5:44.
598 Genome-wide association for methamphetamine dependence: convergent results from 2 samples. Arch Gen Psychiatry. 2008 Mar;65(3):345-55. doi: 10.1001/archpsyc.65.3.345.
599 Intramitochondrial calcium regulation by the FHIT gene product sensitizes to apoptosis. Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12753-8. doi: 10.1073/pnas.0906484106. Epub 2009 Jul 21.
600 Gypenosides protect retinal pigment epithelium cells from oxidative stress. Food Chem Toxicol. 2018 Feb;112:76-85.
601 Role of antioxidant systems in human androgen-independent prostate cancer cells. Prostate. 2000 May 1;43(2):144-9. doi: 10.1002/(sici)1097-0045(20000501)43:2<144::aid-pros9>3.0.co;2-h.
602 Cytotoxic Effects of Cannabinoids on Human HT-29 Colorectal Adenocarcinoma Cells: Different Mechanisms of THC, CBD, and CB83. Int J Mol Sci. 2020 Aug 1;21(15):5533. doi: 10.3390/ijms21155533.
603 Selenium deficiency alters epithelial cell morphology and responses to influenza. Free Radic Biol Med. 2007 Jun 15;42(12):1826-37.
604 Hepatocellular peroxisomes in human alcoholic and drug-induced hepatitis: a quantitative study. Hepatology. 1991 Nov;14(5):811-7.
605 Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatment. Eur Arch Psychiatry Clin Neurosci. 2004 Aug;254(4):231-5.
606 The effect of statins on lipids peroxidation and activities of antioxidants enzymes in patients with dyslipidemia. Przegl Lek. 2006;63(9):738-42.
607 Association between SCN1A polymorphism and carbamazepine-resistant epilepsy. Br J Clin Pharmacol. 2008 Aug;66(2):304-7. doi: 10.1111/j.1365-2125.2008.03203.x. Epub 2008 Apr 11.
608 Identification of potential biomarkers of hepatitis B-induced acute liver failure using hepatic cells derived from human skin precursors. Toxicol In Vitro. 2015 Sep;29(6):1231-9. doi: 10.1016/j.tiv.2014.10.012. Epub 2014 Oct 24.
609 Suppression of cancer relapse and metastasis by inhibiting cancer stemness. Proc Natl Acad Sci U S A. 2015 Feb 10;112(6):1839-44. doi: 10.1073/pnas.1424171112. Epub 2015 Jan 20.
610 Comparison of transcriptome expression alterations by chronic exposure to low-dose bisphenol A in different subtypes of breast cancer cells. Toxicol Appl Pharmacol. 2019 Dec 15;385:114814. doi: 10.1016/j.taap.2019.114814. Epub 2019 Nov 9.
611 CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer. J Clin Invest. 2016 Feb;126(2):639-52.
612 The genome-wide expression profile of Scrophularia ningpoensis-treated thapsigargin-stimulated U-87MG cells. Neurotoxicology. 2009 May;30(3):368-76.
613 Comprehensive analysis of transcriptomic changes induced by low and high doses of bisphenol A in HepG2 spheroids in vitro and rat liver in vivo. Environ Res. 2019 Jun;173:124-134. doi: 10.1016/j.envres.2019.03.035. Epub 2019 Mar 18.
614 Quercetin protected against isoniazide-induced HepG2 cell apoptosis by activating the SIRT1/ERK pathway. J Biochem Mol Toxicol. 2019 Sep;33(9):e22369. doi: 10.1002/jbt.22369. Epub 2019 Jul 23.
615 Drug-induced liver injury: Oltipraz and C2-ceramide intervene HNF-1/GSTA1 expression via JNK signaling pathway. J Appl Toxicol. 2021 Dec;41(12):2011-2020. doi: 10.1002/jat.4181. Epub 2021 May 6.
616 Cytotoxicity of 34 FDA approved small-molecule kinase inhibitors in primary rat and human hepatocytes. Toxicol Lett. 2018 Jul;291:138-148. doi: 10.1016/j.toxlet.2018.04.010. Epub 2018 Apr 12.
617 A Study of Gentianae Radix et Rhizoma Class Differences Based on Chemical Composition and Core Efficacy. Molecules. 2023 Oct 17;28(20):7132. doi: 10.3390/molecules28207132.
618 Arsenic trioxide induces different gene expression profiles of genes related to growth and apoptosis in glioma cells dependent on the p53 status. Mol Biol Rep. 2008 Sep;35(3):421-9.
619 Expression of cytochrome P450 epoxygenases and soluble epoxide hydrolase is regulated by hypolipidemic drugs in dose-dependent manner. Toxicol Appl Pharmacol. 2018 Sep 15;355:156-163.
620 17-Estradiol Activates HSF1 via MAPK Signaling in ER-Positive Breast Cancer Cells. Cancers (Basel). 2019 Oct 11;11(10):1533. doi: 10.3390/cancers11101533.
621 Genistein affects the expression of genes involved in blood pressure regulation and angiogenesis in primary human endothelial cells. Nutr Metab Cardiovasc Dis. 2006 Jan;16(1):35-43. doi: 10.1016/j.numecd.2005.03.003. Epub 2005 Jul 28.
622 10mM glucosamine prevents activation of proADAMTS5 (aggrecanase-2) in transfected cells by interference with post-translational modification of furin. Osteoarthritis Cartilage. 2010 Mar;18(3):455-63. doi: 10.1016/j.joca.2009.10.014. Epub 2009 Nov 4.
623 Coordinate up-regulation of TMEM97 and cholesterol biosynthesis genes in normal ovarian surface epithelial cells treated with progesterone: implications for pathogenesis of ovarian cancer. BMC Cancer. 2007 Dec 11;7:223.
624 Exposure to Insecticides Modifies Gene Expression and DNA Methylation in Hematopoietic Tissues In Vitro. Int J Mol Sci. 2023 Mar 26;24(7):6259. doi: 10.3390/ijms24076259.
625 Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells. J Biol Chem. 2012 Dec 14;287(51):43137-55.
626 Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. Toxicol Appl Pharmacol. 2022 Aug 15;449:116110. doi: 10.1016/j.taap.2022.116110. Epub 2022 Jun 7.
627 A trichostatin A expression signature identified by TempO-Seq targeted whole transcriptome profiling. PLoS One. 2017 May 25;12(5):e0178302. doi: 10.1371/journal.pone.0178302. eCollection 2017.
628 Long noncoding RNA TDRG1 aggravates doxorubicin-induced cardiomyopathy by binding with miR-873-5p to upregulate PRKAR2. Environ Toxicol. 2022 Aug;37(8):2072-2083. doi: 10.1002/tox.23551. Epub 2022 May 7.
629 Human recombinant cytochrome P450 enzymes display distinct hydrogen peroxide generating activities during substrate independent NADPH oxidase reactions. Toxicol Sci. 2014 Oct;141(2):344-52. doi: 10.1093/toxsci/kfu133. Epub 2014 Jul 24.
630 Cytochrome P450 2D6 genotype and steady state plasma levels of risperidone and 9-hydroxyrisperidone. Psychopharmacology (Berl). 1999 Dec;147(3):300-5. doi: 10.1007/s002130051171.
631 Effect of penicillin-based antibiotics, amoxicillin, ampicillin, and piperacillin, on drug-metabolizing activities of human hepatic cytochromes P450. J Toxicol Sci. 2016 Feb;41(1):143-6.
632 Cannabidiol, a major phytocannabinoid, as a potent atypical inhibitor for CYP2D6. Drug Metab Dispos. 2011 Nov;39(11):2049-56. doi: 10.1124/dmd.111.041384. Epub 2011 Aug 5.
633 Identification of human P450 isoforms involved in the metabolism of the antiallergic drug, oxatomide, and its kinetic parameters and inhibition constants. Biol Pharm Bull. 2005 Feb;28(2):328-34.
634 Pharmacokinetics of desipramine HCl when administered with cinacalcet HCl. Eur J Clin Pharmacol. 2007 Feb;63(2):159-63.
635 Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test. Clin Pharmacol Ther. 2001 Oct;70(4):327-35.
636 Interaction of buprenorphine and its metabolite norbuprenorphine with cytochromes p450 in vitro. Drug Metab Dispos. 2003 Jun;31(6):768-72.